Longevity, Aging and DNA Damage: Investigation of the Role of 53BP1 in the Maintenance of Genomic Stability by Croco, Eleonora
 
 
Alma Mater Studiorum – Università di Bologna 
DOTTORATO DI RICERCA IN 
Scienze farmacologiche e tossicologiche, dello sviluppo e del movimento umano 
 
Ciclo 29° 
 
Settore Concorsuale di afferenza: 05/E1 
Settore Scientifico disciplinare: BIO/10 
 
TITOLO TESI 
Longevity, aging and DNA damage:   
investigation of the role of 53BP1 in the maintenance of genomic stability 
 
 
Presentata da: Dott.ssa Eleonora Croco 
 
 
 
 
Coordinatore Dottorato                               Relatore Prof. Claudio Stefanelli 
Prof.ssa Patrizia Hrelia                                Co-relatore Dr. Antonello Lorenzini 
                                                                                                                   
                                            
 
 
 
Esame finale anno 2017 
 2 
 
  
 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 4 
 
CONTENTS 
 
Graphical abstract …………………………………………………………………………………………………….7 
1. Introduction……………………………………………………………………………………….……………………..8 
1.1 Common features of cellular aging………………………………………………….…………………..9 
1.1.1 Telomere attrition ………………………………………………………………………………………9 
1.1.2 Epigenetic alteration. ……………………………………………………………………………….10 
1.1.3 Genomic instability……………………………………………………………………………………11 
1.2 Theories of aging……………………………………………………………………………………………….12 
1.2.1 Free radical theory of aging……………………………………………………………………13 
1.2.2 DNA damage theory of aging………………………………………………………………….14 
1.3 DNA damage………………………………………………………………………………………………………15 
1.3.1 DSB, NHEJ PATHWAY and DNA END BINDING ACTIVITY………………………….16 
1.3.2 Role of 53BP1 in DNA damage recognition…………………………………………….18 
1.3.3 DNA damage foci……………………………………………………………………………………21 
1.3.4 Micronuclei…………………………………………………………………………………………….22 
2.  Aim of the thesis…………………………………………………………………………………………………….24 
2.1 Project description…………………………………………………………………………………………….25 
2.1.1 Part I- DNA damage and species longevity: possible role of 53BP1…………25 
2.1.2 Part II- Genetic instability and aging under the scrutiny of comparative 
biology………………………………………………………………………………………..………….27 
Genomic stability and body mass……………………………………………………………28 
Advantages of the comparative approach………………………………………………29 
Analysis of micronucleated erythrocyte frequency across mammals………29  
2.1.3 Part III- Role of 53BP1 in chronological age…………………………………………….30  
 
3. Material and methods……………………………………………………………………………………………..32 
3.1 Cell culture……………………………………………………………………………………………………..32 
3.2    Freezing and thawing cells………………………………………………………………………………34 
3.3    Genotoxic treatment……………………………………………………………………………….……..34 
3.4    Preparation of whole lysates…………………………………………………………………………..35 
3.5 Polyacrylamide gel electrophoresis………………………………………………………………..36 
 5 
 
3.6 SDS-PAGE and western blotting……………………………………………………………………36 
3.7 Immunofluorescence: foci determination…………………………………………………….36 
3.8 Micronuclei assay…………………………………………………………………………………………37 
3.9       DNA synthesis assessment……………………………………………………………………………38 
3.10 Comet assay…………………………………………………………………………………………………39 
3.11 Cellular viability assay…………………………………………………………………………………..39 
3.12 Cell cycle analysis………………………………………………………………………………………….39 
3.13 Β-galactosidase assay……………………………………………………………………………………40 
3.14 Annexin V assay……………………………………………………………………………………………40 
3.15 CRISPR-CAS9 technology to break down 53BP1 expression………………………….41 
3.16 Preparative restriction digestion…………………………………………………………………..42 
3.17 Ligation, electrophoresis and gel recovery of DNA from agarose gels…………..42 
3.18 Transformation of competent E. Coli……………………………………………………………43  
3.19 Mini prep…………………………………………………..…………………………………………..…….43  
3.20 Maxi prep……………………………………………………………………………………………..……..43 
3.21 Sequencing of plasmids………………………………………………………………………………..43 
3.22 Keratinocytes transfection for stable transformation……………………………………44 
3.23 Clonogenic assay formation………………………………………………………………………….44 
3.24 Survival assay……………………………………………………………………………………………….44 
3.25 Microscopy…………………………………………………………………………………………………..45 
3.26 Data analysis and database…………………………………………………………………………..45 
3.27 Statistical analysis…………………………………………………………………………………………45 
 
4. Results…………………………………..………………………………………………………………………………..48 
4.1 Part I- DNA damage and species longevity: possible role of 53BP1…………………….48 
4.1.1 Measuring toxicity across the species…………………………………………………….48 
4.1.2 Dose response experiments in 53BP1 foci formation……………………………..49 
4.1.3 53BP1 co-localize with γH2AX after 5μM ETO treatment……………………….51 
4.1.4 Long lived species exhibit the highest percentage of 53BP1 foci and 
protein level……………………………………………………………………………………………52 
4.1.5 Genotoxic treatment sinduce 53BP1-PMLnb co-localization and increase 
of senescence in longer lived species………………….………………………………….56  
 6 
 
4.1.6 Genotoxic stress induce cell cycle arrest in all the species….........…………..58 
4.1.7 Long-lived species induce higher level of apoptosis………………………………..61 
4.1.8 Human DNA generally appears more or equally resistant to 
fragmentation………………………………………………………………………………………..61 
4.1.9 Measuring unresolved damage………………………………………………………………64 
4.1.10 53BP1 foci are inversely correlated with micronuclei abundance…………..66 
 
4.2 Part I- 53BP1 down regulation in keratinocytes cell lines…………………………..……...67 
4.2.1 53BP1 knock down clone selection…………………………………………………………67  
4.2.2 Stable 53BP1 knock down clone reduces cellular growth.………………………69  
4.2.3 Down regulation of 53BP1 reduces survival rate  
in response to damage…………………………………………………………………………..69 
4.2.4 53BP1 down regulation is associate to increased genomic 
instability……………………………………………………………………………………………….70 
4.3 Part II- Genetic instability and aging under the scrutiny of comparative biology:  
             a meta-analysis of spontaneous micronuclei frequency…………….……………72 
4.3.1    Body mass and MNEF are inversely correlated……………………………………….72 
4.3.2   Residuals and phylogenetically independent contrasts analyses…………..…74 
4.4 Part II- Role of 53BP1 in chronological age…………………………………………………………75 
4.4.1  Small increase of spontaneous 53BP1 foci in middle and old donors………..75 
4.4.2  Absence of micronuclei increase with chronological age………………………….76 
4.4.3  Higher rate of DNA-SCARS in old donors…………………………………………………..77 
5. Conclusion……………………………………………………………………………………………………………….79 
6. List of references…..………………………………………………………………………………………………..87 
 
 
 
 
 
 
 
                                                                         
 7 
 
Graphical abstract 
In brief: a comparative biology approach offers a powerful observational point, through 
which we aimed to explore the possible link between DNA damage and longevity, by 
investigating the role of 53BP1 protein as a determinant for a long lifespan.  
 
 
Highlights: 
1. A comparative analysis in five mammalian species of 53BP1 repair foci and micronuclei 
expression shows an inverse correlation of these two DNA damage markers: higher 
level of 53BP1 foci are associated to lower incidence of micronuclei formation. 
2. By CRISPR-CAS9 methodology, a 53BP1 knock down model, comparable to the 
difference observed among species, was reproduced: stable downregulation of 53BP1 
is associated to lower survival and increase of micronuclei frequency in response to 
DNA damage. 
3. Spontaneous micronuclei (MN) frequency is inversely proportional to adult body mass. 
4. 53BP1 as DNA damage marker for the aging process: increased spontaneous 53BP1 
foci level and small decrease of repair efficiency are associated to the increase of 
chronological age, in human donors. 
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1.  INTRODUCTION 
 
Aging is a universal and inevitable evolution of life, characterized by global loss of physiological 
integrity and homeostatic imbalance [1] associated to a progressive decline of tissues and 
organ functions, to an impaired ability to respond to stress and to an increasing incidence of 
diseases. All these changes are the results of a side effect of normal metabolism, which is in 
turn exacerbated by environmental influence and unhealthy lifestyle [2]. The general 
worsening of the physiological state, which rise up during aging, is considered the primary risk 
factor for several diseases including neurodegenerative pathologies, diabetes, cardiovascular 
disorders, and cancer [3]. Therefore, death is a consequence of advancing of age. In the last 
decades, the improvements in hygiene and social health led significant increase in life 
expectancy and to a growing number of elderly people worldwide.  
So, now more than ever, modern society has to deal with a whole range of social and health 
problems related to the global population’s aging. The need to solve the aging-related 
problems and the utopian dream of counteracting the effect of time, have prompted the 
scientific community to 
investigate all the 
phenomena related to aging 
and, more in general, to 
longevity. The “systemic” 
aging can be considered as 
the resulting effect of all the 
changes taking place inside 
our body. In fact, the 
physiological basis of these 
phenomena lay in the 
progressive lifelong accumulation of deleterious changes that impair the structure of our body 
at the tissue, cellular and, primarily, molecular level [2]. This is the reason why scientists 
attempted to find some common features of the aging process and tried to elaborate valuable 
theories to explain aging; some of them will be explained in the present work.  
Figure 1: Chronic diseases and aging. Figure from  [2] 
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1.1  Common features of cellular aging 
Aging research has developed deeply in the last decades and, over this time, a growing 
knowledge of the molecular and cellular basis of life and disease has been produced. In 2013 
a group of scientists, driven by the need to conceptualize the basic and common features of 
aging, draw up a “list” of nine hallmarks of aging [3]; these hallmarks are: 1) altered 
intercellular communication; 2) stem cell exhaustion; 3) cellular senescence; 4) mitochondrial 
dysfunction; 5) deregulated nutrient sensing; 6) loss of proteostasis; 7) telomere attrition; 8) 
epigenetic alteration; 9) genomic instability. Only the last three will be presented in this thesis. 
 
 
 
1.1.1  Telomere attrition 
Telomeres are specialized structures of terminal repeated sequences of DNA, which lay at the 
extremity of each chromosome. During every cell division, a small part of the telomeric DNA 
is inevitably lost, due to the inability of DNA polymerase (which in human is active in the 
germline and stem cell lines, but not in somatic cells) to replicate the DNA ends. the 
consequence of this physiological process is the gradual shortening of telomeres, the 
alteration of the telomeric structure and, consequently, replicative senescence [4][5].  
Figure 2: The hallmarks of aging. Figure from [3] 
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Telomeres can be regenerated by the activation of the telomerase enzyme; for example 
ectopic expression of telomerase can promote immortalization of primary cell culture, 
without inducing oncogenic transformation [6]. Telomeres’ shortening is a phenomenon 
occurring both in human and in mice, as a feature of normal aging [7] . In fact, it has been 
showed that  telomerase deficiency in human is associated with premature development of 
diseases, such as pulmonary fibrosis, dyskeratosis congenita, and aplastic anemia, diseases 
connected to the loss of the regenerative capacity of different tissues [8]. Experimental 
evidence support that the same hypothesis is valuable in mice, where telomere length is 
associated with aging and control of lifespan: mice with shortened or lengthened telomeres 
exhibit respectively decreased or increased lifespans length [9][10][11].  
Since it has become clear that in most cases what it is limiting replicative capacity in vitro is 
telomere shortening [6], telomere biology has been deeply investigated also across species in 
cell culture systems [12][13][14]. Stuart et al. [15] clearly showed that telomerase activity is 
low or absent and telomeres are short in long lived and large species and the opposite is true 
in short and small species. Than it is reasonable to suggest that convergent evolution is at play 
using short telomere and absence of telomerase activity as a protective mechanisms to limit 
tumor growth. Larger species, in fact, having more cells, have more potential targets to 
transformation; additionally, long lived species have more time to accumulate tumor 
predisposing mutations. This contradiction is clearly summarized into the  “Peto’s paradox” 
which states that  the risk to develop a tumor per gram of tissue is 3 trillion times smaller in a 
human than in a mouse [16].  Moreover it has been widely shown that telomerase activity is 
linked to tumorigenesis, as well: a big percentage of tumors, which generally originate from 
the transformation of somatic cells, exhibits absence of telomeres shortening and restoration 
of telomerase activity, with the consequence of unlimited growing capacity and inhibition of 
replicative senescence.  
All these evidence led to the idea that telomere attrition, in mammals, can be considered a 
common feature of physiological aging. 
 
1.1.2 Epigenetic alteration  
Conrad Waddington (1905–1975) defined epigenetics as “the branch of biology which studies 
the causal interactions between genes and their products, which bring the phenotype into 
being” [17]. More in general epigenetic can be defined as a set of changes which alter the final 
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outcome of the expression of a locus or a chromosome, without changes in the correspondent 
DNA sequence. In this context, the idea that many of the epigenetic changes which arise 
during organisms’ development and growth may be involved in the aging process started to 
spread. For example chromatin remodelling, posttranslational modification of histones, as 
increased histone H4K16 acetylation, as well as modification of the DNA methylation patterns 
(H4K20 or H3K4 trimethylation, as well as decreased H3K9 methylation) have been showed to 
be related to age-associated epigenetic marks [18][19]. In fact some epigenetic markers that 
are remodelled during reprogramming (like the above mentioned DNA methylations, post-
translational modifications of histones and chromatin remodelling) are impaired during aging 
[20][21][22]. Moreover, cellular differentiation may be also considered an epigenetic 
phenomenon, largely governed by epigenetic changes, accordingly to Waddington, rather 
than alterations in genetic inheritance [23]. Thus, epigenetic dysregulation has emerged as 
one of the key hallmark of the aging process [1]. Studies on the SIRT6, a stress responsive 
protein deacetylase and mono-ADP ribosyl-transferase enzyme involved in epigenetic 
changes, showed that its loss of function reduces longevity; on the contrary SIRT6 gain of 
function was associated to an extended longevity in mice [24][25]. Furthermore, the discovery 
of the Yamanaka factors, also known as “reprogramming factors” (the transcription factors 
Oct4 (Pou5f1), Sox2, cMyc, and Klf4), supports the idea that epigenetic changes have a strong 
influence on lifespan length and opens a new era on the epigenetic studies. Several groups 
have observed an amelioration of age-associated cellular phenotypes during in vitro cellular 
reprogramming [26][27][28][29]. It has been also shown that cellular reprogramming 
obtained by transient expression of Yamanaka factors ameliorated age-associated symptoms, 
prolonged lifespan in progeroid mice, and improved tissue homeostasis in older mice [30]. 
Taken all together, these works suggest that understanding epigenetic mechanisms is a 
fundamental step towards an improvement for the cure of age-related pathologies and for 
extension healthy lifespan.  
 
1.1.3  Genomic instability 
The DNA integrity and stability are constantly challenged by exogenous physical, chemical, 
and biological agents; but endogenous activity, such as DNA replication, spontaneous 
hydrolytic reactions and reactive oxygen production, can also represent a source of damage 
which may impair DNA integrity. Several scientific evidences strengthen the idea of a tight link 
INTRODUCTION 
12 
 
between genomic stability and aging. The most important experimental evidence comes from 
the observation that several progeroid syndromes, such as Werner syndrome, Bloom 
syndrome, xeroderma pigmentosum, trichothiodystrophy, Cockayne syndrome or Seckel 
syndrome are characterised by defects on DNA damage repair pathways [31][32][33]. Somatic 
mutations accumulate within cells from aged humans and model organisms [34]. Other forms 
of DNA damage can accumulate during aging: Faggioli et al. showed an increase of 
chromosomal aneuploidies in the brain of aged mice [35] and Forsberg et al. identified in 
human an association between aging and the copy-number variations, in vivo  [36]. 
Genomic instability can also induce structural and numerical chromosome aberrations in 
somatic cells which, if not properly repaired, can lead to dangerous outcomes for cell’s life.  
An investigation on the efficiency of the spindle assembly checkpoint, which is a critical 
element in regulating chromosome segregation by preventing chromosome mis-segregation 
and aneuploidy, showed that its efficiency is higher in large species; thus species’ longevity 
does not appears as a key factor [37]. Although this analysis suggests that an increased 
efficiency of the spindle assembly check point could be more important for evolving large body 
size than longevity, this does not exclude the possibility that aneuploidy may negatively affect  
life span. Baker et al., in fact, report that mice with low levels of the spindle assembly 
checkpoint protein BubR1, display progeroid features, dwarfism, lordokyphosis, and short 
lifespan [38]. Moreover they showed that transgenic mice overexpressing BubR1 exhibit an 
increased protection against aneuploidy and cancer, and extended healthy lifespan [39]. All 
these data together suggest that maintenance of genomic stability is an important feature in 
order to achieve long lifespan length. 
 
1.2 The theories of aging 
Multiple theories have been proposed to explain the aging process with significant 
experimental support, and it is easy to understand that the various theories of aging can 
overlap at different levels of organization. In the 90’s, Kowald and Kirkwood elaborated a 
theory according to which a “single-factor” process strived for explain the complex mechanism 
of aging, assuming that a single cause could be responsible for this phenomenon [40]. But in 
biogerontology there is a growing appreciation that the process of aging is a multifactorial 
process and that it may not operate in similar fashion in all species [41]. This is probably 
because different species have evolved different strategies to counteract spontaneous 
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molecular damage and random malfunctioning of biological machineries. The different 
efficiency of these strategies could explain the different rate of aging observed across species 
[42] and why aging is not a universal process [43]. So based on evidence that several 
mechanisms may interact simultaneously operating at different levels of functional 
organization, the "single-factor" theory of aging was completely replaced by the vision that 
aging is the result of a complex multifactorial process, characterized by physiological, genetic 
and molecular changes that occur over time, as determined by intrinsic, extrinsic 
(environmental) and stochastic (spontaneous changes within molecules) causes that involve 
all living species. Therefore, it is possible to speculate that several “single-factor” theories 
alone can explain just a part of the phenomena, but cannot clarify the aging process in its 
entirety. Although there are many theories regarding aging, in the present thesis we will deep 
analyse just two of these theories, which are mostly accredited by the scientific community 
and useful for the present discussion: 1) free-radicals theory of aging (FRTA); 2) DNA damage 
theory of aging. 
1.2.1   Free-radical theory aging 
The free-radical theory of aging is based on the hypothesis that aging is the result of the 
cellular accumulation of oxidative damage, as a consequence of reactive oxygen species (ROS) 
released by the mitochondria. We are all living in an environment which leads to ROS 
production and it has been extensively demonstrated that the concentration of free radicals 
growss with the increase of metabolic activity [44]. Moreover it is supposed that the individual 
reactivity or resistance to free radicals stress is improved over time, indeed it is not a pre-
determined factor. DNA molecules, proteins and lipids are all possible targets of  oxidative 
damage that occur at cellular level [45]. The FRTA in fact suggests that 1) the production of 
mitochondrial ROS determines the rate of aging; 2) over time, free radicals are produced 
faster; 3) with aging, damage caused by ROS production is no longer efficiently repaired. 
Differences in how different organism handle oxidative damage were also found among the 
mammalian species. Some authors suggest that long-lived species produce lower levels of ROS 
when compared to short-lived species;  while others demonstrated that rodents under caloric 
restriction live longer and produce less ROS when compared to controls [46]. 
Rossinni used and tested the FRTA to explain the exceptional longevity of M. lucifugus 
(maximum lifespan= 34 years). In a comparative study, the O2 consumption and the 
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production of mitochondrial H₂O₂ in several organs (heart, brain and kidneys) was measured 
in M. lucifugus (little brown bat, long-lived bat) and Blarina brevicauda (short-tailed shrew , 
short-lived). As supposed by the FRTA, M. lucifugus produced about half of the amount of 
H₂O₂ produced by the short-tailed shrew. Rossinni aimed also to observe oxidative damage, 
due to the high metabolic rate associated with the flight in M. lucifugus. Thus, in order to 
evaluate potential differences in oxidative damage, he measured and compared the O2 
consumption and the production of H₂O₂ in both adults and young individuals (fully developed 
and able to fly). Surprisingly and against his hypothesis, young individuals had significantly 
higher levels of H₂O₂ production when compared to adults. The supposition of Rossinni was 
that lower production of free radicals in adults could be the result of a selection, in the 
individual, of efficient mitochondria, caused by the selective pressure due to the high energy 
level required to fly [47].  
In invertebrates oxidative damage, in particular the level of superoxide, does not appear to be 
critical to determine species longevity; instead, in mammals, the effect of oxidative stress on 
lifespan’s length is poorly understood yet, but several authors claimed the potential role of 
antioxidant treatments as a protection against age-related organ dysfunction and cognitive 
decline [48]. Despite numerous scientific evidences proving that antioxidants introduced by 
the diet may reduce the ROS accumulation in rodents without extending lifespan, another 
study showed that mice with mutations in the superoxide dismutase (SOD) are more prone to 
develop pathologies and die prematurely. Anyhow, hyper-ubiquitous expression of SOD does 
not extend lifespan of these animals; therefore, this enzyme does not regulate longevity [49]. 
Numerous studies showed a link between the dysfunction of the respiratory chain, oxidative 
damage induced by ROS activity, and aging in the majority of the model organism[50]. All 
these evidences taken together suggest that oxidative stress is a determinant factor involved 
in aging.  
1.2.2 DNA damage theory of aging 
For a long time, accumulation of molecular damage has been considered key factor for the 
aging process [51]. The theory of DNA damage dates back to the late 50’s when Failla [52] and 
Szilard [34] independently hypothesized that accumulation of DNA lesions maybe be the 
driving force of the aging process. It is now clear that DNA mutations and chromosomal 
abnormalities increases with age in mice [53] and humans [54], and that longevity is correlated 
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with the ability to repair the DNA [55]. It is interesting to note that the more serious progeroid 
syndromes (Werner's syndrome, Hutchinson-Gilford, and Cockayne) originate from mutations 
which impair genes involved in DNA repair and metabolism [56]. 
The emerging hypothesis suggest that only certain types of DNA lesions are crucial for aging 
and this would explain why mutations falling in certain DNA repair genes affect aging, while 
others do not. A recent study, through an analysis of the genes involved in the DNA repair, 
showed that genes related to non-homologous repair mechanism are closely associated to 
aging  [57]. In addition, damage to DNA that interfere with transcription appear to contribute 
to senescence exerting effects on signalling and cellular aging [31].  
 
                     Figure 3: Schematic representation of cellular aging. Figure adapted from [58].  
Understanding which aspects of DNA biology play a role in aging is still a challenge. Although 
it is well known that DNA changes over time could play a very important role in aging, the 
mechanisms which lag behind these changes have to be completely clarified. 
1.3 DNA damage 
DNA is constantly exposed to exogenous and endogenous damaging sources which may 
threaten DNA molecules, generating several types of DNA lesions. In order to preserve 
genome integrity, cells have evolved complex mechanisms which allow to point out and detect 
the presence of the DNA. Connecting to the DNA damage theory of aging, it is possible to 
hypothesize that the capacity to detect molecular damage is a potential cellular determinant 
of longevity. Thus, the detection of the presence of damage is a necessary step in order to 
proceed with repair or, if the damage is irreparable, with other means of damage control, as 
the induction of cellular senescence or apoptosis. Collectively these mechanisms have been 
termed as the DNA damage response (DDR). There is a growing evidence that the DDR 
efficiency can be also modulated by reorganization of the chromatin in answer to DNA damage 
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[59]. In fact the DDR machinery needs to exploit its function on a molecule, DNA, which is 
tightly wrapped around histone proteins in the form of chromatin [60]. Albeit chromatin acts 
as a physical barrier to DNA recognition and repair, it can be modified by some structural 
changes which take place consequently to DNA damage, such as hystone methylation [61] or 
histone post-translational modifications [62], which in turn can facilitate DDR’s function. In 
the context of the DDR activation, the most documented chromatin modification is the 
phosphorylation of the histone variant H2AX (γ-H2AX) [63]. Thus, the DNA damage response 
is a complex scenario where repair proteins are recruited at the lesion’s site and  chromatin-
associated proteins are mobilized to and from DNA breaks [64].  
 
1.3.1   DSB, NHEJ pathway and DNA end binding activity 
Among the different types of DNA damage, the most harmful and dangerous lesions are 
double-strand breaks (DSBs): one unrepaired DSB is sufficient to trigger permanent growth 
arrest and cell death [65][66][67]. DSB can be induced by endogenous and exogenous causes: 
physiological causes which include V(D)J recombination and class switch breaks (AID / UNG / 
EPA); or external factors as ionizing radiations, ROS production, the action of enzymes on the 
nuclear DNA (including topoisomerase II) and mechanical stress [68]. To repair DSBs, 
mammals have evolved two major repair pathways: non-homologous end-joining (NHEJ) and 
homologous recombination (HR). The majority of DSBs in mammals are repaired by NHEJ  [69]: 
in the adult body, the majority of cells, are in G0 phase and, whereas HR is typically active only 
during the S and G2 phases, NHEJ is active throughout the cell cycle [70]. Additionally, NHEJ is 
significantly faster than homologous recombination [71].  
NHEJ can be categorized in two different alternative pathways: 1) the canonical NHEJ (c-NHEJ), 
which involves core proteins such as Ku70, Ku80, DNA-PKcs, Artemis and the Ligase IV complex 
(Lig IV, XRCC4, and XLF) [72]; and 2) the alternative NHEJ (alt-NHEJ), also called 
microhomology-mediated end joining (MMEJ) a DNA-PK-independent repair mechanism, 
which uses a distinct set of proteins, including but not limited to PARP-1, CtIP, XRCC1, and 
Ligase III [73][74][75][76][77][78][79]. NHEJ is also regulated by SIRT6 [80] and Werner 
syndrome proteins [81]. In vertebrates, the Ku heterodimer (composed by Ku70 and Ku80 
proteins) is the first proteic complex to be recruited at the DNA damage site; its recruitment 
to the double strands lesion is a fundamental step in order to activate the NHEJ pathway. Due 
to its ability to recognize and bind DNA free ends, Ku forms a ring structure at the level of the 
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damaged DNA free ends [82]; once loaded on the DNA damaged ends, it functions as a scaffold 
for the assembly of all other proteins involved in the NHEJ pathway.  
 
                                    Figure 4: Model for repair of a DSB by NHEJ. Figure from [83]. 
 
This complex secondarily interacts with the DNA dependent protein kinase (DNA-PKcs) 
(catalytic subunit), forming the DNA-PKcs complex, necessary for the recruitment of ATM 
(Ataxia telangiectasia mutated), which in its turn promotes phosphorylation of the H2A 
histone variant, H2AX, at the site of Ser 139 (called γ-H2AX)[84] and the recruitment of p53 
binding protein 1 (53BP1) at cleavage site [85]. DNA-PKcs also induces the phosphorylation of 
other factors such as Artemis, an enzyme whose 5 '> 3' single-stranded exonuclease activity is 
switched to 5 'end and 3' endonuclease activity once bound to DNA [86]. The final step of the 
repair process consists in the ligation of the DNA broken ends through the intervention of 
LIG4, XRCC4 and XLF (Figure 4) [87].  
Thus, efficient detection of the presence of DNA lesion appears to be a fundamental event for 
a proper cellular answer to DNA damage. Several experimental hypothesis suggest that DNA 
end-binding activity appears to be more closely related to longevity, than other mechanisms 
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of genomic surveillance. Stamato and colleagues showed a striking positive relationship 
between DNA-end binding and species longevity. This is a property which is strictly ascribable 
to the Ku70/Ku80 protein heterodimer [88]. What made this relationship interesting is the 
lack of a correlation between DNA-end binding activity with species adult body mass. The 
underlying hypothesis is that the different abundance of the proteins involved in the early 
phase of NHEJ (the Ku heterodimer and DNA-PKcs) might likely explain the different binding 
activities observed across the species [13].  
Indeed, other mechanisms of genomic surveillance such as poly(ADP-ribose) polymerase 
(PARP) activity [89] and the repair of UV induced DNA lesions [90][91],  positively correlates 
both with longevity and body mass; see dedicated reanalysis in [92][15]. For example, mice 
with loss-of-function mutations in Ku70, Ku80, and SIRT6 each as well as Werner syndrome 
patients exhibit symptoms of premature aging [93][94][95][96][25][97]. So far, the 
appearance of accelerated aging in human patients and in mouse models with mutations in 
genes involved in NHEJ is the strongest evidence supporting the relation which link together 
impairment of the NHEJ and aging. These mutant studies, however, do not tell us whether 
NHEJ is affected during normal aging [98]. 
1.3.2 Role of 53BP1 and its role in DNA damage recognition 
In the presence of DSBs, 53BP1 is recruited at the level of DNA breaks. 53BP1 is a large DNA 
damage sensor and oligomeric chromatin reader of 1972 amino acids. It is characterised by 
the absence of an apparent enzymatic activity and by the presence of several structural 
domains which can directly interact with DSB-responsive proteins.  
 
   Figure 5: Domain structure of the mediator/adaptor proteins 53BP1. Figure adapted from [99]. 
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Among these important structural elements, 53BP1 includes the UDR domain, the BRCA1 
carboxy-terminal (BRCT) repeats, the tandem Tudor domains and 28 amino-terminal 
Ser/Thr‑Gln (S/T‑Q) sites, which are phosphorylated, at least in part, by the ataxia 
telangiectasia mutated (ATM) kinase5 [65]. The UDR domain is used for DNA recognition of 
the damaged site, in order to form nuclear foci (protein agglomerates) in response to a double 
strand breaks, where it can co-localize with other DNA damage response proteins such as γ-
H2AX, Rad50/Mre11/NBS1, BRCA1, and Rad51. The BRCT domain, indeed, is involved in the 
interaction with p53. Notably, 53BP1 owes its name to the ability to bind p53 and precisely 
through this interaction it was originally identified [100]. But, while the role of 53BP1 in the 
DDR pathways has been deeply studied and its contribution completely clarified, 53BP1 
involvement to p53-dependent cellular activities remain still undefined. Cuella-Martin et al. 
carefully investigated the influence of 53BP1 activity upon p53-depedent signalling after DNA 
damage; they demonstrated that 53BP1 stimulates genome-wide p53-dependent gene 
transactivation and repression events in response to ionizing radiation (IR) and synthetic p53 
activation. Overall, these experimental reports suggest that these two functions are 
structurally separated and independent [101]. In figure 6 53BP1’s interactive targets are 
described in detail.   
 
Figure 6: 53BP1 has two structural and functional domains. 1) The UDR domain leads 53BP1 
to be rapidly relocated at DNA damage site after cellular exposure to ionizing radiation (IR); 2) 
the tandem BRCT (BRCA1 C terminus) motif, through which 53BP1 directly binds p53 
enhancing p53-mediated transcription of reporter genes. These two functions can be fully 
separated: mutations in the 53BP1 protein sequence can selectively impair its enrichment at 
nuclear foci or impede p53 binding. When UDR domain is impaired, cells are more sensible to 
IR displaying a decrease survival. If the BRCT domain is impaired, cells show improved survival 
after irradiation [85][101]. 
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53BP1-dependent NHEJ is also crucial in the immune system, where it is necessary for 
immunoglobulin class switch recombination (CSR) and T cell receptor rearrangements 
[102][103]. It was observed that 53BP1 knockout mice (53BP1 -/-) have a severe reduction of 
CSR, thus, results in an over immunodeficiency [104][105]. In order to foster DNA recognition 
and to promote NHEJ, 53BP1 binds a combination of methylated (H4 Lys20me1/2) and 
ubiquitinated histone’s (H2A ubi-Lys15) epitopes within DSB-associated chromatin [106]. 
Through the Tudor domain, 53BP1 is recruited to H2AK15 and H4K20 hystones, which are 
respectively ubiquitylated by RNF8- and mono-dimethylated by RNF168. But the first step 
towards its recruitment is the formation of the MRE11–RAD50–NBS1 (MRN) complex, which 
is a sensor of DNA lesion.  
 
              Figure 7: The signal transduction of 53BP1 pathway. Figure adapted from [65]. 
 
Once MRN complex is aggregated at the level of DSB lesion, it induces auto-phosphorylation 
of active ataxia-telangiectasia mutated (ATM), which in turn phosphorylates the histone 2A 
(H2A) variant H2AX at Ser139, in order to generate γ-H2AX. γ-H2AX is in turn recognized by 
mediator of DNA damage checkpoint protein 1 (MDC1). MDC1 activates a positive feedback 
loop by recruiting more MRN complexes and activated ATM to the damaged chromatin. This 
event leads to the recruitment of the E3 ubiquitin ligase RING finger 8 (RNF8) 
(phosphorylation-dependent). MDC1 linked to RNF8 is recognized by a second E3 ubiquitin 
ligase, RNF168.[65][85]. This last complex, as previously mentioned, recruits 53BP1 to the DNA 
damage surrounding chromatin (Figure 5). Moreover, it was found that 53BP1 foci formation 
is reduced in response to a reduction of the H4K20 methylation [107].  
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Additionally, 53BP1 possesses tumor suppressor functions. Germline 53BP1 mutations 
predispose mice to T cell lymphoma, in manner exacerbated by p53 loss [108][109]. Ward et 
al. showed that 53BP1 mice knock out display a higher sensitivity to IR and an increase rate of 
tumorigenesis [110]. On the whole, these informations track the “portrait” of a key protein, 
fundamental for the cellular destiny after a DNA damage.  
1.3.3 DNA damage nuclear foci   
As previously mentioned, 53BP1 agglomerates in 
clusters at double break sites and these clusters are 
generally called nuclear foci. Nuclear foci are 
agglomerates of DNA damage repair proteins, each with 
a different but necessary function, which form into the 
nucleus of stressed cells within minutes after damage. 
53BP1 foci, as well as all the different nuclear foci, are 
easily identifiable trough immunofluorescence assays 
and are universally used as a DNA damage marker 
[111]. Nowadays very much is known about the role 
and the kinetics of the DNA damage repair complex 
assembly. For example the phosphorylation of the histone variant H2AX (γ-H2AX) and the 
accumulation of the 53BP1 protein in distinct nuclear foci [112] are widely used as DSBs 
markers; γ-H2AX phosphorylation promotes the formation of a protein scaffold necessary for 
the repair of DBSs [113]. Depending on the extent of the damage, γ-H2AX and 53BP1 may co-
localize [114] and, since each focus represents a single DSB, their amount is proportional to 
the intensity of damage [115]. Therefore, nuclear foci represent not only a marker of the 
presence of DNA damage but also a measure of the damage’s intensity.  
Kinetic of nuclear foci, such as 53BP1 foci, can be divided in two temporal phases: 1) early foci 
which rapidly form after damage and are a sign of an active detection DNA damage system; 2) 
long lasting foci which, if DNA damage is not properly repaired, can persist for longer time into 
the nucleus. Moreover, the nuclear location of these persistent foci define two different 
classes of long lasting foci: 1) if foci localized at the telomeres  are called Telomere Dysfunction 
Induced Foci (TIF) [116]; 2) if  foci are localized  all over the nucleus, will be called DNA-SCARS 
(segments of DNA with chromatin alterations) and they can persist for several days after 
Figure 8: Representative 
image of 53BP1 foci in a 
human primary fibroblast. 
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damage [45]. DNA SCARS, which may include both γ-H2AX and 53BP1, often completely or 
partially co-localize with PMLnbs (promyelocytic leukemia protein nuclear body) [117][118]. 
PMLnbs are small dynamic nuclear bodies found in most cell-lines and many tissues. They 
belong to the nuclear matrix in a structure which has been proposed to regulate many nuclear 
functions as DNA replication, transcription, or epigenetic silencing [119]. They may also 
participate to cellular responses to genotoxic stress [120]. Although their biological role is not 
completely clarified, they are often associated to stress induced senescence [121]. In fact 
persistent foci are usually abundant in tissues undergoing to genotoxic stress [122] and in 
senescent tissues of mice and primates [116].  
1.4.4. Micronuclei  
Another well-known DNA damage marker are 
micronuclei (MN). MN formation is widely considered 
as a cytogenetic direct marker of unresolved damage 
and the analysis of their appearance is used as a 
measure of the residual genomic instability in a 
cellular population, after a genotoxic stress. MN are 
defined as small, round, DNA containing cytoplasmic 
bodies derived by loss of nuclear material, not 
incorporated into the nucleus of a daughter cell after 
an aberrant mitosis [123] [124] (fig 8). Thus, MN can 
be constituted by different nuclear portions: acentric 
chromosomes, chromatid fragments or whole chromosomes. MN generation is strictly 
connected to the action of chemical or physical agents which induce, in vivo and in vitro, 
genotoxic stress. Mutagenic agents can be classified into (1) clastogenic agents, able to give 
rise to or induce disruption or breakages of chromosomes, leading to chromosomal deletion, 
insertion or rearrangements or (2) aneugens agents, that damage the mitotic spindle or the 
centromere of a whole chromosomes [125]. Both mutagenic mechanisms lead to a separation 
of portion of chromatin from the main nucleus, in favour of the formation of a new structure 
similar to the main nucleus, but independent and smaller when compared to it [126]. Fenech 
et al. draw a list of characteristics which need to be applied in order to correctly identify MN. 
Thus MN, must  1) be round or oval shaped 2) to lay close to the main nucleus 3) have a 
Figure 9: Representative image of a 
micronucleated nucleus. 
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diameter between 1/3 and 1/16 of the diameter of the main nucleus 4) have the same staining 
intensity and the same appearance of the latter [127] (see Figure 9). Because cell division is 
necessary for the generation of MN, it is recommended that MN are scored by the cytokinesis 
block micronucleus (CBMN) assay developed by Fenech and Morley [128]. Therefore, the 
presence of micronuclei in the cellular cytoplasm is considered an indicators of genetic 
damage.
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In mammals, species lifespan can vary by more than 100 fold (shrew 2 years, bowhead whale 
211 years). It would be plausible to think that differences in lifespan may reflect structural 
differences between species at the cellular level by influencing fundamental processes. The 
DNA damage theory of aging, mentioned above, postulates that accumulation of mutations 
over time is one driving force of the aging process; additionally one may ask whether 
accumulation of DNA damage could also have determined the average lifespan of a species, 
during evolution.  Accordingly, less efficient repair systems of a given species could leave more 
frequently unsolved damages in the cellular population, thus leading to increased genomic 
instability, which in turn would decrease the overall longevity of the species. This hypothesis 
is supported by the observation that a positive correlation exists between longevity and the 
ability to repair damage in model organism [55]. In addition, it has been shown that the 
abundance of proteins like Ku80 and DNA-PKcs, which are directly involved in DNA end-
binding during DSB repair, correlates with the longevity of certain species [13]. 
This thesis aims at further verification of the hypothesis that the efficiency of DNA damage 
repair, which likely contributes to the individual aging process, is also suited to explain the big 
difference in longevity observed in different mammalian species. Specifically, I intended to 
test whether long-lived species have more efficient cellular DNA repair machineries and 
investigated potential differences among five mammalian species, with respect to DNA 
damage-repair and the maintenance of genomic stability in response to low and high 
genotoxic damage.  
53BP1 is widely known as a key regulator and orchestrator of the cellular response to double 
strand break damage: on one hand it is directly recruited on the DNA damage site and on the 
other hand it regulates cellular responses through its direct interaction with p53. Thus, 53BP1 
should be investigated to assess the efficiency of the DNA damage response in the 
comparative experimental model. In addition, formation of micronuclei should be monitored 
to evaluate long-term effects of genotoxic stress in these different species. And finally, similar 
experiments should be applied to cultures of primary skin fibroblasts from human donors of 
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different age to explore a potential association between DNA damage, senescence markers 
and the chronological age. 
2.1 Project description 
The project has been structured in three parts, each investigating the same theme from 
different observational point of view: interspecies longevity, in vitro studies (PART I); 
interspecies longevity, in vivo studies (PART II) and intraspecies longevity ex vivo and in vitro 
studies (PART III). 
2.1.1   PART I- DNA damage detection by 53BP1: relationship to species longevity 
Croco E., Marchionni S., Bocchini M., Angeloni C., Stamato T., Stefanelli C., Hrelia S., Sell C., 
Lorenzini A. 
Abstract 
In order to examine potential differences in genomic stability, we have challenged fibroblasts 
derived from five different mammalian species of variable longevity with the genotoxic agents, 
etoposide and neocarzinostatin. We report that cells from longer-lived species exhibit more 
tumor protein p53 binding protein 1 (53BP1) foci for a given degree of DNA damage relative 
to shorter-lived species. The presence of a greater number of 53BP1 foci was associated with 
decreased DNA fragmentation and a lower percentage of cells exhibiting micronuclei. These 
data suggest that cells from longer-lived species have an enhanced DNA damage response. 
We propose that the number of 53BP1 foci that form in response to damage reflects the 
intrinsic capacity of cells to detect and respond to DNA harms. 
INTRODUCTION 
Double-strand breaks (DSBs) are the most harmful DNA lesions a cell can encounter. In 
mammals, non-homologous end-joining (NHEJ) is the cellular mechanism responsible for 
repairing the majority of DSBs [69]. This is because NHEJ is much faster than homologous 
recombination (HR) [71] and it is active throughout the cell cycle, whereas HR is typically active 
only during the S and G2 phases [70]. Moreover, the majority of cells in the adult body are in 
G0. At the sites of DSBs, nuclear foci of phosphorylated histone H2AX (γ-H2AX) and tumor 
protein p53 binding protein 1 (53BP1) can be detected by immunofluorescence and are widely 
used as DNA damage markers since their abundance has been reported to correlate very 
closely with the degree of genotoxic insult [reviewed in [129]. 53BP1 accumulates in DNA 
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damage foci after the occurrence of DSBs in order to facilitate NHEJ repair [130]. Previous 
works had shown that 53BP1 is involved in activation of the DNA damage response during the 
G1, S, and G2 phases of the cell cycle [131][132][133]. 
We have previously observed an unexpected difference in the formation of DNA damage foci 
between human and mouse cells following exposure to the same concentration of 
neocarzinostatin (NCS). Despite similar exposure to the DNA-damaging agent, human cells 
exhibited a significantly greater number of 53BP1 foci compared with mouse cells. The greater 
abundance of foci in human cells correlated inversely with the appearance of micronuclei, 
which represent the presence of severe genomic damage [134]. We have also reported an 
impressive correlation between mammalian longevity and the capacity of nuclear proteins to 
bind DNA ends, which appears to be largely dependent on increased expression of the 
evolutionarily highly conserved heterodimer Ku80/Ku70 [13]. The DNA end-binding assay 
represents the accumulation of proteins required for the initial DNA damage recognition, a 
necessary step before a cell can proceed with repair, cell cycle arrest or apoptosis. These data 
persuaded us to conduct a deeper investigation into the relationship between the appearance 
of markers of DNA damage and mammalian longevity. 
To this end, we have compared fibroblast cells from mouse (maximum life span, 4 y; weight, 
20.5 g), cow (maximum life span, 20 y; weight, 750 Kg), dog (maximum life span, 24 y; weight, 
40.0 Kg), little brown bat (maximum life span, 34 y; weight, 10.0 g), and human (maximum life 
span, 122 y; weight, 62.0 Kg) in their response to the genotoxic insult caused by etoposide 
(ETO) and neocarcinostatin (NCS). ETO is a poison that binds reversibly to topoisomerase IIα/β 
to block re-ligation of cleaved DNA strands, causing DSBs [135] while NCS is a macromolecular 
chromoprotein antibiotic that causes single- and double-strand breaks [136]. Our 
experimental approach was based on the assumption that the biological mechanisms that 
facilitate longevity are cell autonomous and thus will be reflected in fundamental cellular 
processes. Consequently, these mechanisms can be studied in cell culture away from the 
complexity of the whole organism. For example, using a cell culture approach, Dostàl and 
colleagues have demonstrated that long-lived rodent species are more efficient in excluding 
Cadmium that is known for disturbing DNA base excision and mismatch repair [137]. 
With the present work, we propose that quantitative, species-specific differences in 53BP1 
foci formation observed following exposure to genotoxic agents correlate with differences in 
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lifespan and adult body mass, suggesting a new interpretation of nuclear foci as markers of a 
species’ ability to detect and mitigate DNA damage to ensure genomic stability.  
2.1.2 PART II- Genetic instability and aging under the scrutiny of comparative biology: a 
meta-analysis of spontaneous micronuclei frequency  
Eleonora Croco, Silvia Marchionni, Antonello Lorenzini. 
The idea that accumulation of DNA damage may be responsible for the aging process dates 
back to the late 1950s [52][34]. The key aspects of this theory are twofold: the idea that 
damage accumulates with time and the fact that damage to the DNA is of fundamental 
importance. The first concept is easily explainable if we look at many of the lifeless objects of 
our daily life that, after a period of service, accumulate some sort of damage (cars, buildings, 
etc.). These objects are designed to last for a specified time and they maintain themselves well 
for that period. However, damage eventually appears and accumulates due to intrinsic failure 
of their parts, harmful extrinsic factors, and lack of proper maintenance and repair. The result 
is a period of good function followed by a gradual decline. Biological systems are similar: there 
is a period of low mortality up to a point, followed by a gradual decline in fitness and increased 
mortality. Linking this concept to longevity, each species possesses an intrinsic design that 
ensures functionality for the life span of that species. Repair of DNA damage is critical to that 
design.  
The second concept, that damage to the DNA is of fundamental importance, is also readily 
understandable thanks to a recent scientific breakthrough. Gibson and colleagues, having 
created the first synthetic life form through the synthesis of a 1.08-megabase-pair 
mycoplasma genome, have de facto demonstrated that DNA has a master role in the hierarchy 
of organic molecules [138]. DNA damage will, in fact, carry consequences at any level of 
biological organization or function (RNA, protein, metabolism, etc.).  
Szilard, in his theory paper “On the nature of the aging process”, discussed “hits” to 
chromosomes that render genes inactive[34]. However, genetic instability may also be 
obtained in the absence of actual damage to the DNA molecule. Aneugens, for example, are 
substances that cause genetic instability by simply interfering with chromosome segregation. 
Genetic, genomic, or chromosome instability are thus broader terminologies that are being 
used progressively more in gerontology [139].  
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Many observations and theoretical considerations support a role for genetic instability in 
aging. In rats, for example, inducing DNA damage with a single dose of ionizing radiation at a 
young age (6 weeks) shortens average life span by 10% for a dose of 1 Gy and 25% for a 3-Gy 
dose [140]. The very existence of more than 150 genes involved in DNA damage repair attests 
to the importance of DNA integrity in sustaining life [141]. Following this reasoning, the 
perturbation of one such repair gene should, to some degree, negatively affect life span. In 
support of this, the Ku heterodimer, comprising the Ku70 and Ku80 polypeptides, is critical for 
double-stand break (DSB) repair. Double mutants, as well as mutants of either Ku component, 
display an approximate 66% reduction in life span, with signs of early aging [96]. Despite a 
dramatic effect of the mutant Ku on life span, not all data are supportive of the theory. Kaya 
and colleagues, for example, have monitored a mutant of Saccharomyces cerevisiae that 
accumulates high levels of mutations. Whereas old wild-type cells with few mutations were 
dying, young mutant cells with many more mutations continued budding [142]. In conclusion, 
although the DNA damage accumulation theory is among the “oldest” of the aging theories, 
discussion of its true relevance is still very active among gerontologists.  
Genomic stability and body mass  
The somatic mutation theory of aging predicts that long-lived species will have superior 
genomic stability. In fact, if alterations at the level of DNA are supposed to be responsible for 
the aging process, these alterations must accumulate at a lower rate in longer-lived species. 
With similar reasoning, we can hypothesize that genomic stability will also be positively 
related to adult body mass. In fact, two species with similar longevity but different adult body 
mass will differ in their total number of cells in adulthood. Consequently, the number of total 
cellular divisions that the genome must sustain, from the creation of the zygote onward, can 
be very different. Additionally, body mass is positively correlated with longevity among 
mammals, birds, amphibians, and reptiles [143]. In the multitude of cellular mechanisms 
involved in preserving genomic stability, some will be more essential in order to guarantee 
longevity, while others will be more essential in order to guarantee the development of 
greater body mass. For example, we have found that the capacity to bind DNA ends (a capacity 
of the Ku heterodimer) correlates with longevity, but not with body mass in 12 mammalian 
species [13]. In contrast, we have found that the efficiency of the spindle assembly checkpoint 
correlates strictly with body mass and more loosely with longevity in six species of mammals 
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[144]. The efficiency of excision repair after UV damage and the activity of Parp, an enzyme 
involved in single-strand break (SSB) repair, are other examples where a correlation is found 
both with longevity and body mass [89][92][91][15].  
Advantages of the comparative approach  
Life span studies may be extremely long lasting, being clearly linked to the life span of the 
tested species. Rats and mice, which require at least three to four years of study, are the most 
studied mammals in the laboratory. Nonetheless, these two rodents are not the best 
representation of the aging process in mammals since their longevities lay at the lowest 
extreme of the vast range of life spans exhibited by this class. Maximum longevity in mammals 
spans 100-fold, from 2.1 years for the forest shrew to 211 years for the bowhead whale (data 
from the AnAge database; [145]). Comparing characteristics of species known to differ 
significantly in longevity represents a unique and powerful approach to aging studies [146]. 
Comparative cellular biology also gives the potential to manipulate the environment and 
challenge cells with different stressors to monitor their differential reactivity (reviewed in 
[15]). In a recent and comprehensive review, Moskalev and colleagues analyzed evidence for 
and against the DNA damage theory cataloguing studies based on Koch-like criteria [34]. The 
authors concluded, in part, that comparative biology data are thus far scarce in the literature 
(both for and against the theory). In the present article, we will demonstrate to the 
gerontological community that comparative biology data are readily available and may need 
only to be extracted from the literature. To this end, we conducted a meta-analysis on 
spontaneous in vivo micronuclei (MN) frequency in mammalian erythrocytes of species with 
different longevity and body mass. Our aim was to search for a possible relationship between 
these two parameters (longevity and body mass) and the propensity to this type of genomic 
instability.   
Analysis of micronucleated erythrocyte frequency across mammals  
MN are small cellular bodies containing genomic material enclosed in nuclear membranes. 
These small bodies are produced during mitosis when a whole chromosome or chromosome 
fragment is left behind by the mitotic spindle and fails to be incorporated into either one of 
the daughter cell nuclei. The spontaneous or induced formation of MN is used as a cytogenetic 
test using different cellular substrates: epithelial cells from mouth swab, lymphocytes from 
blood, and erythrocytes from blood, bone marrow, or spleen [147][148]. Erythrocytes are 
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particularly useful since they naturally expel the nucleus during maturation, but do not expel 
the MN [149]. With staining such as Giemsa or acridine orange, micronucleated erythrocytes 
(MNE) are scored to assess the possibility of genotoxicity in vivo [150]. Observing MN in bone 
marrow erythrocytes may testify to recent genotoxic damage, while the presence of MN in 
circulating erythrocytes is an indication of chronic exposure [151]. If the aging process is seen 
as an accumulation of damage, then it may be likened to a chronic exposure. Consequently, 
we have screened the literature for reports on the spontaneous frequency of MN in circulating 
erythrocytes in different species of mammals. 
2.1.3   PART III- 53BP1, DNA DAMAGE AND CHRONOLOGICAL AGE 
The aging process is accompanied by an accumulation of cellular damage, which compromises 
the viability and function of cells and tissues. Dermal fibroblasts are mostly quiescent cells 
that are regularly exposed to environmental stimuli, thus these cells provide a paradigmatic 
model of long-term cellular adaptation to exogenous stress [152]. One of the biggest goal in 
the aging field is to find markers which can be applied for early identification of aging process. 
Human diploid fibroblasts have been used as the election model for in vitro-studies of cellular 
aging, but so far, only a small amount of information about the aging process of these cells in 
their physiological tissue environment, i.e. the dermis , is known [153]. Since DNA damage 
markers can be easily identified and studied, the major part of these studies attempted to find 
an association between their expression and aging. In a recent study, numbers of 53BP1 foci 
in dermal fibroblasts were also positively associated with the age of the donor [154]. 
Fibroblasts in the dermis of aged baboons exhibit accumulation of nuclear foci positive for 
53BP1. Many of these foci are co-localised with telomere markers suggesting they indicate 
telomere dysfunction [155]. Micronuclei numbers were shown to be higher at older age in 
lymphocytes (reviewed in [156]) and buccal cells [147]. However, an inverse relation between 
the number of 53BP1 foci and micronuclei has also been described between mouse and 
human cells [134]. In our work [157] a wide cohort of individuals with different chronological 
age was tested, in vitro, for the presence of two DNA damage markers: MN and 53BP1 foci 
formation. The expression of these two markers was investigated in untreated and rotenone 
treated primary fibroblasts from 100 donors. No association between micronuclei and 
chronological age was found; DNA damage foci of cultured fibroblasts are significantly 
associated with chronological age, but not with biological age, of donors.        
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     Figure 10: 53BP1 foci dependent on chronological age. Figure adapted from [157].
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3. MATERIAL AND METHODS 
 
3.1 Cell culture 
All fibroblast strains and lines used are described in Table 1. Fibroblast strains from mouse, 
little brown bat, dog, and cow were established as previously described [158]. Adult human 
fibroblasts were obtained from Claudio Franceschi (DIMES, University of Bologna).  
Fibroblasts from mammals species were maintained in Minimum Essential Medium (MEM) 
with Earle’s Salts and L-glutamine containing 10% fetal bovine serum (FBS), MEM vitamins and 
amino acids, and penicillin-streptomycin (all from Sigma Aldrich, St. Louis, Mo). Fibroblasts 
were passaged weekly, washing them twice with PBS 1X and using Trypsin-no EDTA 1X for 
detaching the cell layers. The number of cells were counted using the Burker chamber and 
they were seeded according to the standard cell density (10.000/cm²). Cumulative population 
doubling (PD) was determined as previously described [159].  
Skin fibroblast from 15 human female donors were used in the present study. They were aged 
20, 23, 25, 26, 26, 40, 41, 42, 43, 49, 60, 62, 63, 64 and 67 years, thus covering a wide age 
spectrum 20 – 67 years. They were divided into three different chronological age groups, each 
with five biological replicates: “young” (20–30 years), “middle aged” (40–50 years) and “old” 
(60–70 years). All these strains were provided from Prof. Boege (Uniklinik, University of 
Düsseldorf).  
HaSK-pw keratinocytes (KT) (characterised by Petra Boucamp, German Cancer Research 
Center, Heidelberg, Germany), spontaneously immortalized keratinocytes, described in [160], 
were kindly provided from Prof. Boege (Uniklinik, University of Düsseldorf). They were 
maintained in FAD II medium, a 3:1 mixture of DMEM and Ham's F12 medium supplemented 
with 10% FBS, 24 ng/ml Adenin, 1 ng/ml hEGF, 0.4 μg/ml hydrocortisone, and 5 μg/ml insuline. 
The KT cell line was authenticated by short tandem repeat (STR) profiling confirming its 
uniqueness. KT were passaged 1:5 every three days, in order to avoid high confluence level.  
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All cell strains were maintained at 37°C in a humidified atmosphere containing 5% CO2. With 
the exception of the immortalized 3T3 mouse line and keratinocytes, little brown bat strains 
that had undergone spontaneous immortalization, lines displayed cellular senescence and 
were used for all experiments at approximately the first half way through their replicative 
lifespan.  
TAB.1 Cell culture strains and lines 
STRAIN 
NAME 
SPECIES 
COMMON NAME 
(strain) 
ORIGIN (Age) EXPERIMENTS 
MEF Mus musculus Mouse Embryo, F FOCI, MN, 
M3M Mus musculus Mouse Adult (3 months), F 
FOCI ETO, MN, WB, 
MTT 
M2W Mus musculus Mouse Young (2 weeks), F 
FOCI ETO, MN, WB, 
MTT 
 
3T3 Mus musculus Mouse 
Embryo 
(Immortalized) 
FOCI NCS, MN, 
COMET 
YA35CF Homo sapiens Human Adult (25 years), F FOCI, MN, WB, MTT 
IMR90 Homo sapiens Human Embryo, F 
FOCI, MN, COMET, 
WB 
WI38 Homo sapiens Human Embryo, F FOCI, MN 
B#1 Bos taurus Cow 
Young (about 6 
months), F 
FOCI, MN, COMET, 
MTT 
D#1 Canis familiaris Dog (Beagle) Young adult, F 
FOCI, MN, COMET, 
MTT 
D#BAS Canis familiaris Dog (Basset hound) Young adult, F WB, MTT 
LBB#4B Myotis lucifugus Little Brown Bat 
Young adult, 
(immortalized), F 
FOCI, MN, COMET, 
MTT 
 
KT Homo sapiens Human Immortallized, KT 
GENOME EDITING, 
MN, SURVIVAL 
ASSAY, CFA 
F20-F67  Homo sapiens Human 
 
 Adult, F                 FOCI IRRADIATION,  MN 
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3.2  Freezing and Thawing of cells 
In order to freeze cells, they were collected, counted and cellular suspension was centrifuged 
at 300 x g for 5 minutes. The cellular pellet was suspended, according to the standard cellular 
density, in freezing medium (FBS 70%; complete MEM 20%; DMSO 10%), previously prepared 
and stored at 2°-8°C until its use. The suspension was transferred into crio-tubes. After an 
overnight passage at -80°C, tubes were transferred into liquid nitrogen for long term storage.  
For thawing cells, tubes from liquid nitrogen were warmed in the water bath at 37°C for 1 
minute. Cells were mixed and suspended in 5-10mL of fresh MEM and seeded in T25 or T75 
flask. The day after, fresh new medium was added. 
3.3  Genotoxic treatment 
Two different type of genotoxic treatment were performed 1) radiomimetic treatment, ETO 
and NCS treatment; 2) ionizing radiation (IR) treatment.  
1) For the chemical treatment, cells were treated with ETO and NCS (both from Sigma 
Aldrich, St. Louis, Mo). The majority of the experiments were performed on S phase 
synchronized cells and when unsynchronized cells were used, this is specified. S phase 
was chosen as the most appropriate time for exposure to genotoxic stress, accordingly 
to a previous study where differences in susceptibly to genotoxic damage  were 
determined between human and mouse cells, showing that susceptibility is most 
apparent in S-G2 [134]. Additionally, topoisomerase II inhibitors are most effective 
during DNA replication in S phase [161]. Cultures were initially arrested in G0 by serum 
starvation for 48 hours (h) in serum-free medium. Cells were then stimulated to enter 
the cell cycle by the addition of fresh complete medium with 10% FBS. For each 
species, the time following FBS stimulation required for entry into S phase was defined 
by cell cycle analysis (data not shown). Mouse and bat cells were stimulated in 
complete medium with 10% FBS for 16 h; dog, cow, and human for 18 h. Once 
synchronized, cells were treated in complete serum-free medium to avoid the 
potential for interference of serum on drug bioavailability. Unsynchronized cells were 
used only on initial dose response experiments (Figure 14 and 15). Dose ranging from 
5 µM to 100 µM of ETO and ranging from 0.13 µM to 1.35 µM of NCS were used. 
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2) IR treatment was performed by the use of the Gulmay’s machine, available at a 
separate facility of the University of Dusseldorf. All the IR experiments were performed 
on unsynchronized cells, under the same condition of voltage (150kV) and amperage 
(15mA). Time exposure is described in Tab. 2.  
  
 
 
 
 
3.4  Preparation of whole cells lysates 
Cell whole lysates from fibroblasts derived from mouse, little brown bat, dog, cow and human 
were prepared by adding ice-cold RIPA buffer (50mM Tris, 150mM NaCl, 1% NP-40, 0.1% SDS, 
0.5% sodium deoxycholate, 1mM PMSF, 1 µg/mL leupeptin, 1 µg/mL pepstatin). Lysates were 
collected and protein amount was dosed by using DC protein assay (5000111, Bio-Rad kit), 
based on a modification of the Lowry’s method. A standard curve was prepared by obtaining 
3-5 standards of protein (Bovine Serum Albumine, BSA), containing from 0.2 mg/ml to about 
1.5 mg/ml protein. For the dosage, samples were prepared according to manufacturers’ 
instructions. Then, to determine protein concentration absorbance was read at 750 nm.   
To collect whole lysates from primary fibroblasts from young, middle, old donors and for KT 
(wild type and knock down) pellets were resuspended in 2X lysis buffer (250 mM Tris-HCl, pH 
6.8, 2% glycerol, 4% SDS, 20 mM DTT, 1.4 M urea, 20 mM EDTA, 2 mM PMSF, 5 mM pefa block, 
0.04% bromphenol blue) in a volume sufficient to get a final density of 1x10⁵cells/ 20 µl. Thus, 
lysates were homogenized by ultrasound (10 s at 20% power).  
All samples where boiled (100°C, 5 min). 50 micrograms of cell extracts or 30 µl of warm 
aliquots were loaded onto SDS-polyacrylamide gels. 
 
 
TAB.2 Ionizing radiation settings  
Gy TIME    
1 1’23”    
4 5’33”    
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3.5  Polyacrylamide gel electrophoresis 
Electrophoresis was performed in 1x TGS buffer running buffer at voltage of 90-160V. 
3.6  DS-PAGE and Western blotting  
After separation, proteins were electrophoretically transferred from the gel to a nitrocellulose 
membrane by the tank-blot method. Therefore the nitrocellulose membrane was activated in 
MeOH for 1min, washed in H2O and equilibrated in transfer buffer (48 mM Tris, 39 mM glycin, 
0-20 % methanol, pH ~9.2), while the gel was equilibrated for at least 20 min in transfer buffer. 
After transfer, the nitrocellulose membranes were blocked for 1 h in 5% bovine serum albumin 
(BSA) or Milk in Tris-buffered saline containing 0.1% Tween-20 (TBST). Membranes were 
incubated with 5% BSA or Milk TBST primary antibody shaking overnight and then were 
incubated for 1 h with goat anti-mouse-HRP or goat anti-rabbit-HRP (Cell Signalling, Billerica, 
Ma) in 5% BSA or Milk TBS-T. Blots were washed in TBS-T and incubated with ClarityTM 
Western ECL substrate (Bio Rad, Hercules, Ca) for 5 minutes before devoloping. Densitometry 
measurements were captured using the ChemiDoc station and software (Bio Rad, Hercules, 
Ca). All densitometric measurements were normalized to loading controls. 
3.7  Immunofluorescence: foci determination 
Fibroblasts were seeded onto glass coverslips, and treated with ETO or NCS at varying 
concentrations for 6 or 2 h respectively. Cells were fixed at the indicated times after the 
beginning of damage in 3,7 % paraformaldehyde for 10 minutes and permeabilized in 0.5% 
Triton X-100 in PBS for 15 minutes. Cells were washed three times in PBS and blocked for 1 
hour in 5% goat serum 1% BSA in PBS containing Tween-20 (PBST) (blocking solution), after 
which they were incubated with primary antibody in 0,1% blocking solution buffer for 1 h at 
room temperature in a humidified chamber.  All the antibodies used are listed in Tab. 3. 
53BP1 antibody (NB 100-304) binds, in tested species, epitopes with homologies that range 
between 90% and 92% compared to the human epitope. Anti-γH2AX antibody, used for 
human and mouse, binds an epitope with a homology of 90% between these two species. 
Slides were washed three times in blocking solution and incubated with secondary antibody  
in 0,1% blocking solution for 1 h. Cells were washed three times, stained with DAPI, and 
mounted with Vectashield mounting medium (Vector Laboratories, Burlingame, Ca) before 
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visualizing. Images were captured using an Olympus BX61 fluorescence microscope (Tokyo, 
Japan) equipped with a Hamamatsu ORCA-ER camera (Hamamatsu City, Japan) or an Olympus 
IX50 equipped with a Diagnostic Instruments 9.0 Monochrome - 6 camera (Sterling Heights, 
Mi). Clearly identifiable 53BP1 or γH2AX foci inside the nucleus were counted as positive foci. 
Nuclei were scored as containing: 53BP1 foci (F) < 5; 5 ≤ F < 20; F ≥ 20. Nuclei with fewer than 
5 foci were considered foci-negative because this number of foci was common in untreated 
cells. Overlapping and/or contiguous 53BP1 and PML foci were scored in co-localization 
experiments. 
3.8 Micronuclei assay 
Unsynchronized cells or cells synchronized in S phase, as previously described, were treated 
with ETO or NCS at varying concentrations for 6 or 2 h, respectively; or with IR at different 
grade of irradation. At the times indicated in each figures, cells were fixed in 4% 
paraformaldehyde for 10 minutes and permeabilized in 0.2% Triton X-100 in PBS for 1 minute. 
Fixed cells were stained with DAPI and washed with PBS. Cells were mounted with Vectashield 
and scored using fluorescence microscopy as above. Micronuclei, defined as DAPI-positive 
bodies that were morphologically identical but smaller than the nucleus, were scored 
according to Thomas and Fenech [127]. Cells were considered micronucleus-positive if they 
contained, at least, one micronucleus.  
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3.9 DNA synthesis assessment 
Fibroblasts were seeded onto glass coverslips, synchronized as described above, and treated 
with 5μM ETO for 6 h. 10μM Bromodeoxyuridine (BrdU) pulse, with different lapse of time, 
was performed to assess DNA synthesis. Cells were fixed at the desired time point, as 
previously described, and were treated with 1M HCl for 45 minutes at room temperature. HCl 
was then neutralized with borate buffer and cells were washed once in PBS and blocked for 
30 minutes in 4% BSA in PBST. Cells were incubated with an anti-BrdU antibody in 1% BSA-
PBST buffer for 2 h at 37°C in a humidified chamber. Slides were then washed three times in 
PBST and incubated in AlexaFluor488-conjugated goat anti-mouse secondary antibody in 1% 
BSA-PBST for 1 h to label BrdU incorporation. 
TAB.1 Antibodies’ list  
EPITOPE COMPANY    
53BP1, NB 100-304 Novus Biologicals, Littleton Co 
   
anti-β-actin, A5441 Sigma Aldrich, St. Louis, Mo    
Nek4 (2631C1a), sc-81332 Santa Cruz Biotechnology, Dallas, Tex    
cyclin A (H-432), sc-751 Santa Cruz Biotechnology, Dallas, Tex 
   
Calnexin, #PA5-34665 Thermo Fisher Scientific, Ma    
anti-mouse-HRP or goat anti-rabbit-HRP  Cell Signalling, Billerica, Ma    
γ-H2AX ,05-636, clone JBW301,  Merck Millipore, Billerica, Ma    
PML Antibody (PG-M3), sc-966  Santa Cruz, Dallas, Tex    
AlexaFlour555-conjugated goat anti rabbit, 
#4413S 
Cell Signaling, Danvers, Ma 
   
AlexaFluor488-conjugated goat anti-mouse, 
#4408S 
Cell Signaling, Danvers, Ma 
   
anti-BrdU , clone BU20A eBioscience, San Diego, Ca    
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3.10 Comet assay 
The microgel electrophoretic technique was performed utilizing the neutral lysis method 
which detects DSBs [162]. From a population of synchronized cells, a single-cell suspension 
was prepared by trypsin disaggregation. Disaggregated cells were counted and treated with 
50 µM ETO and 1.35 μM NCS, respectively for 60 and 30 minutes, at room temperature and 
were then re-suspended in 1% low-melting agarose. The low-melting cellular suspension was 
seeded onto slides and cells were lysed by placing the slides in a humid chamber at 37°C with 
2% SDS, 0.05M EDTA, 0.5 mg/ml proteinase K for at least 18 h. Lysis was performed under 
neutral conditions to detect DSBs. After lysis, slides were washed two times in 0.5X TBE buffer. 
Electrophoresis was carried out at 30 v/cm for 15 minutes in 0.5X TBE buffer. For visualization 
of DNA damage, slides were stained with DAPI and observed using fluorescence microscopy 
as described above. Cells with DNA damage appeared as comets. One hundred comets were 
scored for each species and each time point, and analysed with Open Comet [163] image 
analysis software. Individual comet images were scored for several features including tail 
length and percentage DNA in tail. 
3.11 Cellular viability assay  
Fibroblast viability was evaluated in terms of mitochondrial activity, by conversion of the dye 
MTT to insoluble formazan [164]. Cells were seeded in 96-well plates and treated with 5 and 
50 μM of ETO and 0.13 and 1.35 μM of NCS for 6 and 2 h, respectively. At the times indicated 
(24, 48 and 72h), cells were washed with PBS and incubated in MTT (5 mg/mL) in PBS for 2 h. 
After removal of MTT, formazan crystals were dissolved with DMSO (all from Sigma Aldrich, 
St. Louis, Mo) and the amount of formazan was measured at λ = 570 nm (ref. λ = 690 nm) with 
a spectrophotometer (Victor2 Multilabel Counter, PerkinElmer, Waltham, Ma). All 
experiments were repeated at least two times, with each comprising an evaluation of five 
wells per treatment. Mitochondrial activity in treated cells was calculated as a percentage 
relative to control cells according to the formula: (absorbance of treated 
fibroblasts/absorbance of untreated fibroblasts) × 100. 
3.12 Cell cycle analysis 
Cells were harvested by trypsinization, washed in PBS, and fixed overnight in 70% ethanol at 
4 °C. Ethanol was removed by centrifugation and cells were washed with PBS, then 
MATERIAL AND METHODS 
40 
 
resuspended and incubated 30 minutes at room temperature in Guava Cell Cycle Reagent 
containing propidium iodide. Cells were analyzed for DNA content on a Guava EasyCyte Mini 
flow cytometer using the Guava Cell Cycle program (Guava Technologies, Hayward CA). 
3.13 Beta-gal assay 
Β-galactosidase assay detects senescent cells in a given population by staining the β-
galactosidase activity. Providing to the cells an exogenous substrate, X-gal, this will be lysed 
by the enzyme causing the blue colour of senescent cells, appreciable at the microscope. 
Human (y#18) and mouse primary fibroblasts were synchronized in G0 for 48 hours by serum-
free starvation and then fresh complete medium was added for 18 and 16 hours, respectively 
in human and mouse, to induce entry in S phase. Once synchronized, cells were treated with 
0,13 µM of neocarzinostatin (LD-NCS) in serum-free medium for 2 hours. Then LD-NCS was 
removed, cultures were washed, complete fresh medium was added to the culture plates and 
cells were incubated for 24 hours. At this time point, fibroblasts were washed twice with 
PBS1X and processed according to manufacturer’s instructions (Senescence Cells 
Histochemical Staining Kit, CS0030-1KT Sigma Aldrich, St. Louis, Mo.) After staining, all the 
samples were washed three times with PBS1X and incubated for 48 hours. To avoid 
acidification of the medium due to CO2 exposition, which can inhibit Beta-gal activity, plates 
were carefully sealed during incubation. For each sample a total number of 200 cells was 
counted. The percentage of senescent cells was determined by scoring the number of cells 
blue staining positive for the beta-gal assay, on total number. 
3.14 Annexin V assay 
Annexin V assay allows detection of apoptotic and necrotic cells in a given cellular population. 
This assay includes the evaluation of Annexin V, a probe which binds to phosphatidylserine 
exposed on the external membrane of apoptotic cells, and 7-AAD, a cell impermeant dye, as 
an indicator of membrane structural integrity. 7-AAD is excluded from live, healthy cells and 
early apoptotic cells, but permeates in late-stage apoptotic and dead cells. For the evaluation 
of the presence of apoptotic cells, unsynchronized primary human and mouse fibroblast were 
used. Fibroblasts were seeded and, one day later, were treated with 100 µM Etoposide (HD-
ETO) for 30 minutes in serum-free medium. After treatment, the medium containing 
Etoposide was removed, cells were washed and fresh medium was added. Then, cells were 
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incubated for 24 and 48 hours. At different time points cells were collected, centrifuged and 
resuspended with Guava Nexin Reagent (4500-0450, Merck Millipore, Billerica, Ma).  Analysis 
of the samples was performed with Guava easyCyte 5HT Millipore cytofluorimeter (Merck 
Millipore, Billerica, Ma). Early apoptotic cells (Annexin V (+) 7-AAD (-)) were gated and scored 
in untreated and treated samples.  
3.15 CRISPR-CAS9 technology to break down 53BP1 expression. 
The type II prokaryotic CRISPR (clustered regularly interspaced short palindromic repeats)/Cas 
is an adaptive microbial immune system, evolved in order to face phages’ infections. It has 
been recently demonstrated that CRISPR nuclease system is able to facilitate genome editing 
in mammalian cells [165]; in fact it facilitates cleavage at the DNA level, with the help of RNA-
guided site-specific. With this approach, it is possible change the target sequence by 
addressing the DSB at the genomic locus supposed to be edited. The DSBs, induced by 
nuclease activity, can be repaired by nonhomologous end-joining (NHEJ) or homology-
directed repair (HDR); NHEJ’s repair choice might efficiently introduce insertion/deletion 
mutations of various lengths which may disrupt the translational reading frame of the coding 
sequence [166]. Knockdown of 53BP1 gene has been programmed by disrupting the 
transduction of the protein by introducing a DSB at the start codon site (ATG triplet, as shown 
in Figure 11).  
  
 
From database (http://crispr.mit.edu/) two guide RNAs (gRNA) have been designed: 
53BP1-AUG_fw  caccGGGGAGCAGATGGACCCTAC 
53BP1-AUG_rv  aaacGTAGGGTCCATCTGCTCCCC 
53BP1 gRNA was cloned inside the pM U6_gRNA plasmid, using the restriction site BbsI (Figure 
12).  
TTCCATTCCAGGGGAGCAGATGGACCCTACTGGAAGTCAGTTGGATTCAGATTTCTCTCAGCA 
Figure 11: 53BP1 sequence from the start codon.  
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3.16 Preparative restriction digestion  
Prior to the gRNA insertion into the linearized plasmid, a preparative restriction digestion was 
used to open the vector. 2 µg of plasmid DNA were digested by restriction enzyme (BbsI) in 
the appropriate buffer for 1 h at 37°C. DNA was then separated by agarose gel electrophoresis. 
And the DNA bands were cut from the gel. DNA was extracted from the gel using a gel 
extraction kit according to manufacturer’s instruction. 
3.17 Ligation, electrophoresis and gel recovery of DNA from agarose gels  
The Quick Ligation kit (NEB), to ligate gRNA fragments and the plasmid, was used according to 
manufacturer’s instructions. Ligation was performed for 10 minutes at RT and then 
transferred to 4°C before transformation. After ligation, DNA fragments were separated by 
agarose gel electrophoresis, accordingly to their molecular size. 1% agarose gel was prepared 
by melting agarose in 1X TAE buffer. EtBr was added to a final concentration of 1 µg/ml. For 
electrophoresis, samples mixed with appropriate volume of 6X DNA loading buffer, were 
loaded onto a gel placed in a proper chamber was covered with 1X TAE buffer. Electrophoresis 
was performed at 120 V for 40 minutes. To check for the length of the inserted DNA fragment 
into the plasmid vector and its correct orientation another analytical restriction digestion was 
performed. 
 
 
Figure 12: pM U6_gRNA plasmid sequence. 
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3.18   Transformation of competent E. coli  
In order to transform competent E. coli, an aliquot of cells (DH5α) (0.2 ml) was mixed with 
ligation reaction mixture, previously prepared (2 µl), and incubated for 30 minutes on ice. To 
open the membrane pores and let the ligation construct enter the cell, DH5α were heat 
shocked at 42°C for 30 sec and immediately transferred to 4°C. LB-media (0.5 ml, warm) was 
added to the cells, mixed and suspension was incubated for 1 h at 37°C under vigorous shaking 
(250 rpm). Then, transformed cells were plated on LB-agar plates containing 50 µg/ml 
ampicillin and allowed to grow not less than 24 h, at 37°C.  
3.19 Miniprep 
Single and well isolated colonies were picked from the selection plate and inoculated in 2.5 ml 
TB selective medium (50 µg/ml ampicillin). Selected colonies were incubated overnight at 
37°C, under shaking. Transformed E.Coli cultures were pelleted; pellets, from each colony, 
were mixed with lysis solution (0.2 N NaOH, 1% SDS), neutralized with NH4oAC (7.5 M) and 
kept on ice (10 minutes) to precipitate genomic DNA. By the addition of 2-propanol, plasmid 
DNA was precipitated from the supernatant. Thus, DNA pellets were air dried and 
resuspended in TE containing RNaseA (50 µg/ml). In order to check the size and the sequence 
of plasmids, isolated DNA undergone restriction digestions and consequent sequencing. 
3.20 Maxiprep  
Plasmid with the right size and sequence, were selected to perform a large scale plasmid 
isolation. Transformed E.Coli were inoculated in a primary culture of 3 ml selective TB selective 
medium (50 µg/ml ampicillin) and incubated for approximately 8 h at 37°C under shaking. 
After a small incubation, starter cultures were diluted into 250 ml selection TB medium and 
grown on large scale overnight under the conditions mentioned above. Bacterial cells were 
harvested and plasmid DNA’s purification was performed using QIAGEN Plasmid Maxi Kit 
according to the manufacturer’s protocol. Then for each sample, DNA concentration was 
determined spectrophotometrically. 
3.21 Sequencing of plasmids  
Sequencing of the constructs was performed by the BMFZ (Biologisch-Medizinisches 
Forschungszentrum) of the Heinrich-Heine-University Düsseldorf (Germany). 
MATERIAL AND METHODS 
44 
 
3.22 Ketatinocytes transfection for a stable transformation 
Prior to transformation, cells were seeded and splitted on day before transfection at 1:4 and 
4/5 dilution, respectively. Cells were transfected with 1 µg of 53BP1 knock down maxi prep 
and Cas-9-RFP tagged (to select transfected clones) were used for keratinocytes transfection 
with the transfection Kit (301425, QIAGEN, Hilden, Germany). Procedure were carried out 
according to the manufacturer’s protocol. Stable transgenic cell clones were selected 48 h 
after transfection and maintained in selective medium containing 100 mg/ml hygromycin. 
Approximately three weeks later, only red clones were selected.   
3.23 Clonogenic Assay Formation Assay (CFA) 
Untreated cells were seeded, in triplicate, in petri dishes at a final density of 1000 cells/plate. 
Cells were incubated until they have formed colonies that were of a substantially good size to 
be scored. The right colony size is defined as a cluster of cells of, at least, 50 cells. After 
discarding medium, cells were at first washed with PBS1X and then fixed for 30 minutes at 
room temperature with pre-iced methanol 100%. 0, 5% crystal violet solution was added to 
the samples, which were incubated at room temperature for 5 minutes. In order to remove 
crystal violet, plates were immerged in tap water and then they were allowed to dry at room 
temperature up to a few days. The number of colonies were counted by a stereomicroscope 
[167].  
3.24 Survival Assay 
Survival efficiency was tested on keratinocytes wild type (KT WT) and 53BP1 knock down 
(53BP1 KD). Cells were seeded 24h prior irradiation and then were irradiated with two 
different doses of ionizing radiation (IR), 1Gy and 4 Gy respectively. After treatment with IR, 
cells were collected, counted and seeded in duplicate on a culture dish (Petri dish) at a final 
density of 240.000 cells/dish. After treatment cells were incubated and allowed to grow for 7 
days. After 7 days, cells were stained with 0,5% of crystal violet solution, as described for CFA. 
Crystal violet was dissolved in acetic acid 100% for 5 minutes. Solved crystal violet was 
collected and absorbance was read at the spectofotometer (495 nm). Untreated and treated 
samples were analysed and results are an average of 4 independent experiments. 
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3.25 Microscopy 
Images were captured using an Olympus BX61 fluorescence microscope (Tokyo, Japan) 
equipped with a Hamamatsu ORCA-ER camera (Hamamatsu City, Japan) or an Olympus IX50 
equipped with a Diagnostic Instruments 9.0 Monochrome - 6 camera (Sterling Heights, Mi). 
3.26 Data analysis and database 
Spontaneous MNE frequency (MNEF) for 65 mammals data were collected through a 
systematic PubMed search. MNEF is known to be higher in erythrocytes of developing 
organisms and to decrease to a certain level in adult life [168]. Additionally, studies performed 
in mice [169] and humans [156] show that during aging there is again an increase in MNEF. 
According to Sato et al., this increase is not observed, or observed only very late in life, in some 
strains of mice [194]. In light of these considerations, we collected data only for adult animals 
for which the approximate age was specified (47 species) and which are reported in Tab.3. 
Additionally body mass (BM) and maximum longevity (ML) values are shown as taken from 
the AnAge Database [145]. More detail about selection can be found in [170]. 
3.27  Statistical analysis  
All results are expressed as the mean ± s.e.m, unless specified. Differences between species, 
treatment or time point were evaluated using ANOVA, followed by Tukey's Multiple 
Comparison Test (* p value < 0.05, ** p value < 0.01, *** p value < 0.001) using Graphpad 
Software Inc (La Jolla, Ca), unless specified. Maximum human longevity is 122 years. In the 
figures captions and in the correlation analysis it is adjusted to 90 years to account for the fact 
that, for the others species, only small cohorts were used to determine maximum life span, 
and 90 years seems a more realistic estimate for a random sample of humans. 
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MAMMALS n MNEF (MNE/10000 TE) 
MAXIMUM 
LONGEVITY 
(years) 
BODY MASS 
(Kg) REFERENCES 
Alouatta palliate 2 3,00 24,0 7,00 Zuniga, 2005 
Antilope cervicapra 1 1,50 23,9 37,50 Zuniga, 1996 
Apodemus flavicollis 18 17,40 4,5 0,03 Abramsson,1997 
Apodemus sylvaticus 12 13,30 6,3 0,02 Abramsson,1997 
Ateles geoffroyi 20 0,67 47,1 7,20 Zuniga,2005 
Bos Taurus 43 1,28 20,0 750,00 Cristaldi, 2004 
Canis familiaris 16 1,22 24,0 40,00 Zuniga, 1996 
Capra falconeri 1 0,00 19,1 41,00 Zuniga, 1996 
Capra hircus 13 0,80 20,8 61,00 Zuniga, 1996 
Cavia porcellus 10 0,30 12,0 0,72 Zuniga, 1996 
Cebuella pygmaea (Callithrix pygmaea) 1 10,00 18,6 0,12 Zuniga, 2005 
Cebus  albifrons 4 20,50 40,4 2,46 Zuniga, 2001 
Cercopithecus aethiops (Chlorocebus aethiops) 4 0,40 30,8 5,62 Zuniga, 2005 
Clethrionomys glareolus 24 4,00 4,9 0,09 Abramsson,1997 
Cryptotis parva 10 24,30 3,5 0,05 Meier, 1999 
Didelphis virginiana 3 1,30 6,6 3,00 Zuniga, 2001 
Equus asinus 9 1,70 47,0 165,00 Zuniga, 1996 
Equus burchelli (Equus zebra) 1 1,20 33,2 296,00 Zuniga, 1996 
Equus caballus 27 2,64 57,0 300,00 Cristaldi, 2004 
Felis domesticus 64 8,52 30,0 3,90 Zuniga, 1996 
Felis ruffus (Lynx rufus) 1 0,50 32,3 8,60 Zuniga, 1996 
Felis yagoaroundi 1 4,50 18,6 7,00 Zuniga, 1996 
Gazella thomsoni 1 4,00 20,0 25,00 Zuniga, 1996 
Giraffa Camelopardalis 1 0,00 39,5 800,00 Zuniga, 2001 
Gorilla gorilla 2 0,90 55,4 139,84 Zuniga, 1996 
Homo sapiens 14 0,40 122,5 62,03 Zuniga, 2005 
Lama glama glama 2 3,50 28,9 140,00 Zuniga, 1996 
Macaca fascicularis 2 0,00 39,0 6,36 Zuniga, 2005 
Macaca mulatta 1 2,60 40,0 8,23 Zuniga, 1996 
Mandrillus sphinx 1 1,00 40,0 23,00 Zuniga, 2005 
Mephitis mephitis 1 2,50 13,9 3,50 Zuniga, 1996 
Meriones unguiculatus 8 9,40 6,3 0,05 Zuniga, 1996 
Mesocricetus auratus 11 6,30 3,9 0,10 Zuniga, 1996 
Microtus agrestis 24 1,20 4,8 0,05 Abramsson,1997 
Mus musculus 22 15,20 4,0 0,02 Abramsson,1997 
Odocoileus virginianus 5 2,30 23,0 87,00 Zuniga, 1996 
Oryctolagus cuniculus  12 1,96 9,0 1,80 Raminez, 1999 
Ovis aries 5 0,80 22,8 80,00 Zuniga, 1996 
Pan troglodytes 1 2,00 59,4 44,98 Zuniga, 2005 
Panthera leo 2 0,60 27,0 175,00 Zuniga, 1996 
Peromyscus leucopus 10 0,00 8,0 0,02 Meier, 1999 
Pongo pygmaeus 2 0,50 59,0 64,47 Zuniga, 1996 
Rattus norvegicus 10 2,20 3,8 0,30 Zuniga, 1996 
Saguinus midas 1 4,00 21,0 0,55 Zuniga, 2005 
Sciurus aureogaster 4 3,50 23,6 0,60 Zuniga, 2000 
Sus scrofa 55 3,77 27,0 130,00 Cristaldi, 2004 
Tamazate americana (Mazama temama) 1 4,00 17,1 33,00 Zuniga, 1996 
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Table 4. Data used in the meta-analysis. All data were used for Figure 37 A, B, C. Only data 
highlighted were used for figure 37 D, E, F and for figure 38; only data highlighted with n ≥ 3 
were used for figure 37 G, H, I; MNEF, MicroNucleated Erythrocytes Frequency; MNE, 
MicroNucleated Erythrocytes; TE,Total Erythrocytes (micronucleated and 
not)[171][172][173][174][148][175]. 
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4. RESULTS 
 
4.1 PART I- DNA damage detection by 53BP1: relationship to species longevity 
 
4.1.1 Measuring toxicity across the species 
The comparative approach performed in the 
present study arises from the hypothesis that 
differences in lifespan may reflect structural 
cellular differences. This experimental 
investigation, in fact, aimed to test whether 
the efficiency of DNA damage repair may also 
explain the big difference in longevity, 
observed across mammalian species. The 
selection of mammalian species enrolled in 
the present experimental model was carried 
out on the basis of two fundamental features 
for an analysis in biogerontology: species 
should cover wide variation in body size mass 
and lifespan length. Primary skin fibroblast 
from mouse, cow, dog, bat and human were 
changelled with two radiomimetic drugs: ETO 
and NCS.  
In primis, it was necessary to monitor cell 
survival and, eventually, to register metabolic 
differences in response to the two selected 
genotoxic damaging agents. A comparison of 
metabolic activity measures was performed. 
 
Figure 13: MTT assay to measure toxicity. Fibroblast viability was evaluated with the 
colorimetric MTT assay in untreated (CTRL) and treated cells (5μM and 50μM ETO; 0.13 μM 
and 1.35 μM NCS) at 24, 48 and 72h after the beginning of treatment. Statistical analysis 
compares treated to untreated controls, for each species.● = p value < 0.05; ○ = p value > 0.05. 
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The MTT assay gives a measure of metabolic activity as the cellular capacity to convert MTT 
to formazan (Figure 13) at 24, 48 and 72h after damage across all the five species. Low doses 
treatments (5 µM ETO or 0.13 µM NCS) induce a low cytotoxic effect in all species and did not 
cause a significant reduction in MTT activity, whereas doses 10 times higher did.  
4.1.2 Dose response experiments in 53BP1 foci formation  
To assess the efficiency of the DNA damage response in the comparative experimental model, 
the role of 53BP1 was investigated across the five species. 
 
Figure 14: Dose-response relationship of 53BP1 foci in unsynchronized cells. 53BP1 foci were scored 
24h after damage both in non micronucleated (light grey bars) and micronucleated cells (dark grey 
bars) after treatment with increasing concentration of NCS (A-D).  
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53BP1, as previously mentioned, is a DNA damage marker and sensor, which rapidly 
accumulates at DNA damage site. Agglomerate of 53BP1 protein are called foci and their 
abundance is directly proportional to the intensity of damage. Thus, to determine time and 
concentrations that would yield a not maximized 53BP1 foci response, preliminary 
experiments with increasing concentration of genotoxics were performed. Human fibroblasts 
(IMR90) were treated for two hours with increasing doses of NCS (CTRL, A; 0.11 μM, B; 0.22 
μM, C; 0.44 μM, D) and then fixed 24h after the beginning of damage. Fixed cells were 
prepared for immunofluorescence to detect 53BP1 and γ-H2AX foci. Data report of an 
experiment on human cells showed that already at a low concentration of NCS (0.22 µM) the 
53BP1 foci response is maximized (i.e. the vast majority of the nuclei have more than twenty 
53BP1 foci each). Similar dose response experiments were performed for ETO (Figure 21). 
Thus, the majority of the experiments were carried out using the lowest concentration able to 
elicit a significant response. A second comparison was performed between mouse (3T3) and 
human (IMR90) unsynchronized cells. Untreated cells (A, C) and cells treated (B, D) with 1.35 
μM NCS, for 2h, were fixed 72h after the beginning of damage. At the highest concentration 
used for NCS (1.35 µM), while the response of the most responsive species (human) was 
totally maximized, the response of mouse cells were still intermediate (Figure 15).  
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A)                                                                 C) 
     
B)                                                              D)  
 
Figure 15: High NCS doses induce massive 53BP1 foci formation in human but not in mouse. Fixed 
cells were prepared for immunofluorescence. A) and B) untreated cells from mouse and human;  C) 
and D)  cells treated with 1.35 µM NCS from mouse and human respectively. 53BP1 foci (f) were scored 
in three categories of cells represented in: 1) Non micronucleated cells (nuclei with regular shape); 2) 
Polylobated (nuclei with irregular shape and nuclear bud); 3) Micronucleated cells (nuclei with regular 
or irregular shape with MN and nuclei with mitotic crisis). 
 
 
4.1.3  53BP1 co-localize with γ-H2AX after 5μM ETO treatment. 
Since published data suggest that long lived species have a better Ku70-Ku80 DNA-end biding 
capacity [13], we speculated that long-lived species could be more efficient in detecting and, 
possibly, repairing DNA DSBs. To prove that treatments used were able to elicit DSBs, a co-
immunostaining experiments for 53BP1 and γ-H2AX was performed. The co-localization of 
53BP1 and γ-H2AX is, in fact, a widely accepted marker of the presence of a DSB [112]. Figure 
16.A shows that, with 5 μM ETO treatment, 53BP1 foci co-localize with γ-H2AX foci in the vast 
majority of cases in both mouse primary and human cells. Between 1, 2 and 10 h after the 
beginning of treatment, every hundred 53BP1 foci, more than eighty 53BP1 foci co-localized 
with γ-H2AX in both species (Figure 16.B).  
MOUSE 
HUMAN 
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Figure 16. 53BP1 and γ-H2AX co-localize in the presence of DSBs. A) Representative 
immunofluorescence of nuclei in fibroblasts stressed with 5μM ETO treatment (γ-H2AX in red, 
53BP1 in green, merge in yellow). B) 53BP1 co-localization with γ-H2AX in nuclear foci 1, 2 and 
10 h after the beginning of 5μM ETO treatment. Statistical analysis: T-Student test followed 
by paired test. Showed are means ± sd of two independent experiments.  
 
4.1.4  Long-lived species exhibit the highest percentage of 53BP1 foci and protein level.  
In order to assess if differences in the efficiency of DNA damage detection machineries could 
be a driving force of the evolution of longevity, 53BP1 appearance was investigated in a 
comparative model. Synchronized primary fibroblasts from five different mammalian species 
(mouse, cow, dog, bat, human), were exposed to either 5 µM ETO or 0.13 µM NCS during S 
phase and were monitored at specific time intervals, from two hours up to three days after 
the beginning of damage. Cells were scored for 53BP1 foci, which were grouped into: f< 5,    
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5 ≤ f < 20 foci and f ≥20 foci per nucleus. The histogram bars show the percent of nuclei with 
53BP1 foci ≥ 5 (obtained summing 5 ≤ f < 20 and f >20). Figure 17 (A and B) shows a time-
course analysis after 5 µM ETO treatment. The time course analysis revealed a peak in 53BP1 
foci formation between 2 and 10 h in all species (Figure 17), followed by a gradual decline in 
the percentage of foci-positive nuclei.  
        A)                                 B)                               B) 
                                                     
                   C) 
 
Figure 17. 53BP1 foci formation kinetic is similar in all the species. Time course curve shows 
the trend of foci formation after 5μM ETO (A) or 0,13 μM NCS (B) treatment, in all species, 
from 0 to 72 h. C) Representative immunofluorescence image of 53BP1 foci formation in 
untreated (CTRL) and 5μM ETO treated human cells, observed 24h after the beginning of 
damage. 
Interestingly, longer-lived species showed a higher percentage of nuclei with more than five 
53BP1 foci. Human cells, derived from the longest-lived species, exhibited the highest 
percentage of foci when compared to all other species, with statistical significance observed 
consistently at 2 and 24 h from the beginning of damage (Figure 18.A and B). More interesting, 
human cells seemed to retain a higher number of foci over time. 
RESULTS 
54 
 
                               
 
 
Figure 18. Longer lived species recruit 53BP1 in nuclear foci at a higher rate. A) Untreated 
(CTRL) and 5μM ETO treated cells were fixed either during and right after treatment at the 
following time points: 2, 6, 10, 24, 48 and 72 h following the beginning; B) Untreated (CTRL 
0.13 μM NCS treated cells were fixed at 24, 48 and 72 h. The respective maximum life span of 
each species is reported in parenthesis in years (y). From 200 to 400 cells were scored twice 
for each sample, from 2 to 6 independent experiments. Statistical significance is referred to 
the comparison of all the species to the equivalent time point in human.  
As previously showed, 24 h were required for visible foci to form in treated with 1.5 µg/mL of 
NCS (0.13 µM) [134]. Accordingly, foci were scored from 24 to 72 h after the beginning of 
damage with this agent. Similar to results with 5 µM ETO treatment, longer-lived species 
exhibited a higher percentage of cells with more than five foci per nucleus in response to 0.13 
µM NCS. Human cells showed the highest percentage of cells with more than five 53BP1 foci 
(Figure 18.A and B). At the opposite, both primary and immortalized 3T3 mouse cells exhibited 
the lowest foci response among the studied species; mouse and cow response were 
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comparable only in the case of ETO treatment. Following genotoxic stress, the steady state 
level of the 53BP1 protein was also assessed. Independently from treatment time, whole 
lysates show a multiband pattern of 53BP1, suggesting the existence of different modifications 
of the protein (Figure 19).  
 
Figure 19. 53BP1 protein expression in response to DNA damage. A) Immunoblot analysis in 
fibroblasts for 53BP1 in lysates from untreated (CTRL) or 5μM ETO treated (+) for 6 h, harvested at 6 
or 24 h after genotoxic treatment.  
 
Densitometric analysis of multiple experiments is shown in Figure 19. It appears that protein 
levels do not change substantially during the 24 h following the beginning of 5 µM ETO 
treatment (except for the 24 h time point in dog cells, figure 20). This suggests that 53BP1 is a 
constitutive protein. Mouse and dog cells have significantly lower level compared with human 
cells. More generally, the larger and/or longer-lived species (cow, bat and human) appear to 
possess higher 53BP1 protein amount although these differences are always below one fold 
(Figure 20). 
 
Figure 20. 53BP1 protein expression after DNA damage. Quantification of 53BP1 signal, normalized 
over actin signal, is representative of two or more independent experiments in untreated (CTRL) and 
5μM ETO treated in fibroblasts. Statistical analysis: T-Student test followed by paired test (two tailed). 
The data from a single species were compared to each individual species for the same treatment time, 
and, inside a single species. CTRL values were compared with 6 and 24 h time points. Significant 
difference (p value < 0,05) between pairs of species is indicated by the presence of a squared bracket 
or by the initials of each species (M = mouse; D = dog; C = cow; B = bat; H = human). 
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4.1.5  Genotoxic treatments induce 53BP1-PMLnb co-localization and increase of 
senescence in long-lived species 
Detection of the presence of damage is a necessary step in order to proceed with repair. But when 
damage is irreparable, cells respond to DNA stress with other means of damage control: primarily, 
cell division can be inhibited through the activities of the tumor suppressor p53, in order to prevent 
the genomic instability; or cellular senescence can be induced. The latter process is well known as 
stress-induced senescence (SIS): it takes place in response to a variety of stressors that include 
DNA damage, changes in the structure of the heterochromatin, strong mitogenic signals resulting 
from the expression of oncogenes or exposure to strong genotoxic stressors [121]. Recently, 
nuclear markers of senescence has been identified as DNA Segments of Chromatin Reinforcing 
Senescence (abbreviated in SCARS). DNA-SCARS, as suggested by Rodier and colleagues, are long-
lasting foci where co-localization of 53BP1 and Promyelocytic leukemia protein (PML) nuclear body 
(nb) takes place [121]. In support of this interpretation and to test if, in the present experimental 
model, treatments performed with genotoxics induced also DNA-SCARS formation, PMLnb and 
53BP1 were co-stained trough an immune-fluorescence on human cells. Human fibroblasts were 
treated, during S phase, with increasing doses of ETO (5, 50, 100 μM) for 6h. Cells were then fixed 
at 24h, 48h and 72h after the beginning of damage. Figure 21 shows that, even with at low 
concentration of genotoxic treatment, a significant increase in the percentage of PML nuclear body 
contiguous to 53BP1 foci is observable at 72h after the beginning of treatment. Since, 53BP1 foci 
formation assay (Figure 18.A and B) showed that all the five species, and in particular human, 
retained 53BP1 agglomerates for long time after damage (72h), we could hypothesize DNA-SCARS 
are induced after low and higher genotoxic treatments.  
RESULTS 
57 
 
                
 
Figure 21. Genotoxic damage induces co-localization of 53BP1 with PMLnb. 53BP1 foci per 
nucleus and percent of 53BP1 foci contiguous to PMLnb were scored in 50 nuclei for each 
experimental condition and time point experiments in untreated (CTRL) and 5μM ETO treated 
in fibroblasts (A). Graphs represent two independent experiments. Statistical analysis: T-
Student test followed by paired test (two tailed); p value < 0.05. B) Representative 
immunofluorescence of contiguous PML/53BP1 foci. 
 
Additionally, the hypothesis that long-lived species are able to induce more efficiently 
senescence was tested and β -gal activity has been measured in human and mouse fibroblasts, 
challenged with a genotoxic stimulus (0.13 µM NCS). Senescence-associated (beta)-
galactosidase (β-gal) is widely used as a biomarker of replicative senescence [176]. In both 
species, β-gal activity was measured 24h after NCS treatment. Data report shows a similar rate 
of senescence in untreated cells but a stronger induction of senescence in human (long living 
species), suggesting that longer lived species are better equipped in activating all the 
mechanism which may protect cells from genomic instability (Figure 22). 
 
B) A) 
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4.1.6  Genotoxic stress induce cell cycle arrest in all the species 
DDR is a complex pathway which exploits its activity by controlling the cell cycle progression 
as well. In order to give to the cell sufficient time to repair DNA damage, cell cycle is usually 
slowed down after a genotoxic insult. With respect to cell cycle control in response to DNA 
damage, DNA content was measured in mouse, dog, cow, and human cells (Figure 23). On a 
Guava EasyCyte Mini flow cytometer, cell cycle progression was monitored in G0 synchronized 
cells (48 h of serum starvation), and stimulated to enter into the S-phase by adding fresh 
regular growth medium. Cells in S-phase were treated with 5μM ETO for 6 h in serum free 
medium. Cells were harvested by trypsinization and fixed overnight in 70% ethanol at 4 °C. 
Fixed cells were prepared for cell cycle analysis by addition of Guava Cell Cycle Reagent 
containing propidium iodide. Cytofluorimetric analysis revealed a significant shift in the cell 
cycle profile in all four species tested. In treated cells, between 2 and 6h after damage, an 
increase of percentage of cells in the S and G2 phases of the cell cycle was observed, especially 
G2 for mouse and S for dog, cow, and human (Figure 23). 
Figure 22:  β-gal activity increases in human cells after high dose genotoxic treatment. 
Mouse and human fibroblast were treated with low doses of NCS and tested for β-gal 
activity, 24h after damage.  
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Figure 23. Influence of DNA damage on species cell cycle. Synchronized fibroblasts from four mammal 
species, were treated for 6 hours with 5 μM ETO. Synchronized population was analyzed at different 
time after damage and up to 16h.  
 
Moreover, Cyclin A and Nek 4 expression was examined trough western blot analysis in species 
for which antibodies with conserved epitopes were available. Both of them in fact, are markers 
used in order to highlight cell cycle progression in a cellular population. Increased expression 
in cyclin A, in all treated cells, confirmed a larger proportion of cells in G2 arrest. (Figure 24).  
 
 
Figure 24.  Immunoblot analysis for NEK4 and CYCLIN A after DNA damage. Lysates from untreated 
cultures (CTRL) or from cultures treated with 5μM ETO for 6 hours, were collected at 24, 48 and 72 h 
after the beginning of the genotoxic treatment. Membranes were exposed for different intervals to 
obtain optimal signals. Actin and ponceau staining (protein) were used as loading controls.  
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This was evident in all species, but especially pronounced in human and cow. In addition, the 
expression of Nek 4, a recently described regulator of both DNA-PK association with DNA 
damage and entry into senescence [177], also increased following damage.     
To further observe differences in the efficiency of cell cycle arrest following damage, we 
exposed mouse and human cells to 5 µM ETO and pulsed them with BrdU. Cells were analyzed 
for the percentage of cells synthesizing DNA (BrdU-positive nuclei) and the percentage that 
harbor BrdU-positive 53BP1 foci (BrdU staining only in damage foci) at time points from 14 to 
72 h after the beginning of damage (Figure 25). For the 14 and 24 h time-points, the cultures 
were pulsed with BrdU for 3 h at 10 h from the beginning of treatment; the 72 h time-point 
was pulsed for 3 h at 24 h from the beginning of treatment. At 14 h, human cell populations 
contained a lower percentage of cells synthesizing DNA compared with mouse cells, but a 
similar percentage of cells with BrdU foci.  
 
 
Figure 25. DNA synthesis after DNA damage in mouse and human cells. Cell populations were 
analyzed for the percentage of cells synthesizing DNA (BrdU positive throughout the nucleus; 
BrdU/TOT) and the percentage of cells that harbor BrdU-positive 53BP1 foci (% Nuclei with BrdU Foci) 
at 14, 24 and 72 h after the beginning of 5μM ETO treatment. 
 
At 24 h, the percentage of cells incorporating BrdU increased for both species, indicating 
progression through the cell cycle. Again, the human population had a lower percentage of 
cells incorporating BrdU, but a higher percentage of BrdU in foci, suggesting a more active 
repair (Figure 25). 
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4.1.7  Long-lived species induce higher level of apoptosis 
An additional mean owned by cells to protect DNA integrity, when DNA damage is irreparable, 
is the induction of apoptosis. To assess whether induction of apoptosis was similar among the 
species, Annexin V assay was performed in unsynchronized untreated and treated (100 μM 
ETO) fibroblasts. Cells were treated and then allowed to recover for 24 and 48 hours after 
damage, both untreated and treated samples. Controls value for each species are indicated as 
1 and values from treated samples were normalized over control. 
                     
Figure 26. Long-lived species induce higher level of apoptosis. Fibroblasts from mouse, cow, dog, bat 
and human were treated with 100 μM ETO and allowed to recover for 24 and 48h. Data represents a 
ratio of treated/ untreated samples. Annexin V(+) 7-AAD(-) cells were scored as early apoptotic. 
Showed are means ± s.e.m of two independent experiments. 
 
Data report values of the ratio of treated over untreated cells Annexin V(+) and 7-ADD(-), 
which represents the portion of cellular population in an early apoptotic state. Graph shows 
that longer lived species (human and bat) induce higher level of apoptosis at both time points 
(24 and 48 hours after damage) (Figure 26). 
 
4.1.8 Human DNA generally appears more or equally resistant to fragmentation  
Overall, data collected on cell cycle control and 53BP1 foci formation addressed simple 
questions to answer: are long-lived more prone to DNA damage, when compared to short 
lived species? Are long-lived species more fragile when challenged with a genotoxic stress? In 
order to investigate this hypothesis, DNA fragility was evaluated after genotoxic stress by 
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comet assay. For DNA damage detection at the individual cell level, the comet assay was 
performed under neutral conditions, which allowed recognition of DSB. Comet tails obtained 
with the 5 µM ETO and 0.13 µM NCS, concentration used in long-term experiments, were too 
short to show significant differences (data not reported). Thus, higher doses of ETO and NCS 
were used for comet assays. Figure 28 shows data from cells treated with 50 µM ETO and 1.35 
µM NCS for 60 and 30 minutes, respectively. Genotoxic treatments resulted in DNA 
fragmentation and the appearance of comet tails. 
 
 
           Figure 27. Representative comets of untreated and high dose treated fibroblasts. 
 
Percentage of DNA in comet tails and tail moments (measures obtained by multiplying tail 
length by percentage DNA in tail) were analysed for all the five species, and data are shown 
as fold increase over untreated. After both treatments, we observed a significant increase in 
the percentage of tail DNA in all species. Although the results of the two measure of DNA 
damage (percent tail DNA and tail moment) did not overlap, cells from the mouse, the 
shortest-lived species in the panel, had significantly greater DNA fragmentation in all 
instances. The longest-lived species (human) and the largest (cow) exhibited the least amount 
of damage in the comet assay (Figure 28).  
Since DNA damage repair is activated within minutes of damage [178], it is possible to 
hypothesise that difference observed among species are a consequence of faster repair 
mechanisms, rather than chromatin structural strength. 
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Figure 28. Human DNA generally appears more or equally resistant to fragmentation when 
compared to other species. Quantification of percent DNA in comets tails (A-B) and 
quantification of Tail moment (C-D) after 50μM ETO and 1.35μM NCS are presented in a box 
plot showing means ± s.e.m and whiskers representing 10-90 percentile.  For both treatments, 
data were obtained from two independent experiments. Statistical analysis: Kruskal-Wallis 
analysis. The data from a single species was compared to each individual species. Significant 
difference (p value < 0, 0001) between pairs of species is indicated by the presence of the 
initials above the box plot for each species (M = mouse; D = dog; C = cow; B = bat; H = human). 
G) Representative comets of untreated (CTRL) and 50μM ETO treated fibroblasts. 
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4.1.9 Measuring unresolved damage 
MN are widely considered a direct cytogenetic marker of unresolved damage. They originate, 
as a consequence of aberrant mitosis, from chromosome fragments or whole chromosomes 
that lag behind at anaphase [127]. To evaluate long-term effects of genotoxic stress in these 
different species and the amount of unresolved damage in each species after genotoxic stress, 
micronuclei formation was scored at 0, 24, 48 and 72 h after the beginning of damage. All cells 
were synchronized in G0 phase by 48 h incubation in serum free medium. Cells were then 
stimulated to enter into the S-phase by adding complete growth medium (10% FBS) as 
described in materials and methods. Cells in S-phase were treated in serum free medium with 
5 μM ETO (A), 0.13 μM NCS (B) or 5 µM ETO  with a BrdU pulse (C, cells were pulsed with BrdU 
for all the length of the treatment); cells were washed and fed with growth medium and 
allowed to recover from damage. MN were scored on a minimum of 400 cells. Surprisingly, it 
was observed that shorter-lived species have a higher percentage of nuclei with ≥1 
micronuclei In particular, mouse, the shortest-lived and the smallest species, showed the 
highest percentage of micronuclei at all time points both after 5 µM ETO and 0.13 µM NCS 
treatments (Figure 29.A and 29.B, respectively). As a demonstration that micronuclei arise 
only in cycling cells, MN were also scored in BrdU-positive cells (Figure 29.C).  
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Figure 29: Short-lived species have higher percentage of Micronuclei (MN). MN were scored 
at 24, 48 and 72 h after the beginning of the ETO (A) and NCS (B) treatments. Means were 
calculated from two to six experiments. MN were also scored in BrdU+ cells (C). In all instances, 
untreated cells (CTRL) are cells at 24 h past complete growth medium addition. The respective 
maximum life span of each species is reported in parenthesis in years (y). D) Dapi staining for 
a representation of MN in all the analysed species.  
 
RESULTS 
66 
 
4.1.10  53BP1 foci are inversely correlated with micronuclei abundance 
To interpret the relationship between 53BP1 foci, micronuclei and lifespan, the data for 53BP1 
foci formation and micronuclei were plotted with species longevity. We used data from the 
72 h time point following the beginning of NCS exposure, since this treatment produces the 
highest number of long lasting foci interpretable as DNA-SCARS. Micronuclei are inversely 
related to long-lasting foci (R2=0.868; p=0.021; Figure 30.A).  
       
 
Figure 30. Correlations of 53BP1 foci and MN with maximum life span and adult body mass. 
Correlations were examined using data collected at 72 h after the beginning of 0.13μM NCS treatment 
for both 53BP1 Foci and MN. Panel A contains the inverse correlation between 53BP1 foci and MN. 
Panels (B) and (C) contain positive correlations between 53BP1 foci and longevity and body mass 
respectively. Panels (D) and (E) contain the negative correlation between MN and longevity and body 
mass respectively. All values were natural logarithm transformed. Coefficient of determinations and p 
values are shown. 
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Additionally, while long-lasting foci were strongly and positively related with longevity 
(R2=0.87; p=0.020; Supp. Figure 9.B), micronuclei were negatively related (R2=0.59), although 
this relationship did not reach significance in this data set (Supp. Figure 9.D). Like maximum 
life span, body mass was also positively related with long-lasting foci (R2=0.36; Supp. Figure 
9.C) and negatively related with micronuclei (R2=0.35; Supp. Figure 9.E), although neither 
association reached significance in this data set. These data suggest that both longevity and 
body mass are related to genome surveillance and stability, but that longevity is more strongly 
related than body mass. 
 
4.2 PART 2- 53BP1 Knock down clones  
4.2.1   53BP1 knock down clone selection 
Analysis of the expression of 53BP1 foci together with MN formation among the species 
showed an inverse association between these two DNA damage markers: a lower amount of 
53BP1 foci is associated to a higher genomic instability, measured as the increase of MN 
formation. To investigate the contribution of 53BP1 in the mechanism underling the 
differences in MN formation, accordingly to a genotoxic stress, 53BP1 knock down clones were 
generated. By CRISPR-CAS9 technology approach, 8 different knock down clones were isolated 
from transfection of isogenic keratinocytes cells and one was selected for the present study. 
Figure 31 shows the keratinocytes wild type (WT) and the eight 53BP1 knock down clones (1-
8). The clone number 3 (red rectangle) was selected for the present experimental thesis.  
 
Figure 31. Immunoblot represents keratinocytes: one wild type sample (WT) and 53BP1 knock down 
clones (1-8). Eight clones were isolated from transfection and clone n° 3 (red rectangle) was selected 
(53BP1 KD), studied and characterized. 
All the experiment concerning 53BP1 knock down clones were performed at “Central Institute 
of Clinical Chemistry and Laboratory Medicine”, University of Düsseldorf. 
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Further immunoblot analysis, from whole cell lysates, showed that the 53BP1 levels were 
reduced of around the 40-50% in 53BP1 KD (Figure 32).  
                              A)                                                               B) 
 
Figure 32: CRISPR-CAS9 approach to reduce 53BP1 level. A) Immunoblot analysis shows wild 
type (WT) and 53BP1 knock down (53BP1 KD) keratinocytes cell lines. B) Signal quantification 
of 53BP1/calenxin (loading control), in three measurements. Signal quantification was 
performed with ImageJ software. Showed are the means +/- s.e.m. 
 
53BP1’s knockdown was also confirmed by immunofluorescence analysis (Figure 33). Despite 
lower level of 53BP1, 53BP1 KD clone is still able to respond to genotoxic lesions, as observed 
in the immunofluorescence of untreated and 4 Gy IR treated cells (Figure 33). 53BP1 stable 
down regulation could be interpreted as a condition which is miming the physiological 
differences found among the species. 
Therefore, assuming that this approach 
may reflect differences observed across 
the species (i.e. mouse and human) in 
the comparative approach, in terms of 
53BP1 abundance, several cellular 
responses were further investigated to 
fully characterize 53BP1 KD clone. 
 
 
Figure 33: Representative immune-fluorescence of WT and 53BP1 KD. Untreated and treated 
cells were stained with 53BP1 probe. Cells irradiated with 4 Gy dose, were fixed at 2 or 24h 
after irradiation. 
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4.2.2 Stable 53BP1 knock down clone reduces cellular growth 
CFA is a useful method to test the survival efficiency of a cell line, in other words it measures 
the ability of cells of a certain cellular population to divide and form colonies after a cytotoxic 
or genotoxic treatment. Here, the CFA approach was used to measure clonogenic growth 
efficiency to determine if down regulation of 53BP1 could impair growth of untreated cell 
lines. WT and 53BP1 KD clones were seeded at standard density and incubated for 2-3 weeks. 
Prior to count, colonies are allowed to reach the size of approximatively 50 cells. Colonies with 
less than 50 cells were not scored. Figure 34 shows that the growth efficiency is reduced in 
53BP1 KD controls, when compared to the WT. This outcome is consistent with data on 53BP1 
MCF-7 knock out, showed in [101].  
                                       
Figure 34: Reduced survival in untreated 53BP1 KD clones. WT and 53BP1 KD were seeded and grown 
for 2-3 weeks. Showed are the means +/- s.e.m. of two independent experiments. Statistical analysis: 
T-Student test followed by paired test. p value < 0,001.  
 
4.2.3  Down regulation of 53BP1 reduces survival rate in response to damage  
53BP1 is a well-known DNA damage sensor and marker. 53BP1 interacts with p53, regulating 
cellular DNA damage pathways p53-dependent [101]. These pathways involve the cell cycle 
regulation and survival. We aimed to evaluate how survival rate changed after ionizing 
radiation, in WT and 53BP1 KD. Keratinocytes from wild type and knock down were seeded at 
the same cellular density one day prior irradiation, which was performed at two different 
doses, 1 and 4 Gy. 7 days after irradiation cells were fixed, stained and analysed.   
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Figure 35: 53BP1 KD shows a lower survival rate after IR. Wild type and 53BP1 KD clones were 
irradiated with 1 and 4 Gy doses and allowed to recover for 7 days. Means +/- s.e.m of three 
independent experiments are represented in the graph. For each experiment, samples were seeded in 
duplicate, and each duplicate read 5 times. Statistical analysis was performed comparing the % survival 
in WT and 53BP1 KD for each experimental condition. Statistical analysis: T-Student test followed by 
paired test. p value < 0,01. 
 
Figure 35 shows the percentage of survival of treated samples compared to untreated, whose 
value was fixed as 100% of survival. In both cell lines, low and high doses treatment induce a 
decrease of the survival of treated cells when compared to the respective control. A 
comparison between the WT and 53BP1 KD clone, for each treatment showed that 1 Gy 
irradiation induces a significant reduction of the survival rate in 53BP1 KD clones; while 
differences between WT and knock down are lower at 4 Gy irradiation. Experimental data 
suggest that 53BP1 is at play in the cellular processes activated in order to survive to a 
genotoxic damage.  
4.2.4  53BP1 down regulation is associated to increased genomic instability 
In order to assess if 53BP1 directly contribute to the process which lead to MN formation in 
response to double strand breaks, MN were blindly scored in WT and 53BP1 KD clones, in 
untreated and treated cells. Cells were seeded one day prior to treatment, treated with 1 and 
4 Gy irradiation and then allowed to recover for 24h. Therefore, since the aim of this 
experimentation was to directly evaluate the presence unresolved damage, MN were scored, 
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approximately after the first division; in other words, 24h after damage. In a preliminary 
experiment, MN were also scored at 72 hours after damage, but the related data are not 
included in the present analysis; it is plausible to speculate that, in a cell line with a high 
proliferation rate, analysis at 72 hours can lead to an inaccurate estimation of MN numbers. 
In fact, due to activation of cellular pathway (i.e cell cycle arrest, apoptosis) in response to 
DNA damage, some micronuclei can be lost or misunderstand with mitotic crisis.  
                            
Figure 36: MN formation increases after IR in 53BP1 KD clones. WT and 53BP1 KD clones were irradiated 
with 1 and 4 Gy. MN were scored 24h, twice, in 500 cells.  Means +/- s.e.m of three blind independent 
experiments are represented in the graph. Statistical analysis was performed comparing the % MN in WT 
and 53BP1 KD for each experimental condition. Statistical analysis: T-Student test followed by paired test. 
p value < 0,001. 
 
53BP1 KD clones, compared to WT, showed an increase of % of MN in all the three conditions 
(0, 1, 4 Gy), but differences are statistical significant only at 1 Gy. Since isogenic cells were 
chosen and differences, between wild type and knockdown clones, lay exclusively in the 
different amount of 53BP1 level, it is possible to state that 53BP1’s down regulation is directly 
responsible of the mechanism leading to an increasing number of MN in response to a DSB 
damage: lower 53BP1 protein levels are strictly connected to higher genomic instability. 
Moreover, the experimental model achieved by CRISPR-CAS9 technology, is a challenging 
approach: no other 53BP1 stable knockdown models are available in non-transformed cells.  
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4.3 PART II- Genetic instability and aging under the scrutiny of comparative biology: a                 
meta-analysis of spontaneous micronuclei frequency 
 
4.3.1   Body mass and MNEF are inversely correlated 
In order to test if spontaneous micronuclei frequency is associated to longevity in mammals, 
a comparative meta-analysis of pre-existing data has been performed. As a first step, a 
correlation analysis between the log10 transformed values of MNEF, body mass and maximum 
longevity for all 47 species reported in Tab.4, was performed. The comparisons between these 
data could be weakened by factors related to peculiar differences in the circulatory systems 
of the species and to different modalities of erythropoiesis. For example, polychromatic 
erythrocytes (immature erythrocytes) are absent in the peripheral blood of some species 
[172]. A major problem was represented by the capacity of the spleen, in some species, to 
selectively eliminate MNE. This issue could be eliminated analysing micronuclei in 
reticulocytes that are not eliminated by the spleen even in species with a filtering organ 
[151][179]. Unfortunately, the available data on micronucleated reticulocytes are extremely 
scarce in comparison with the available data on mature erythrocytes. Udroiu has addressed 
the spleen filtration issue using data from haematological studies, histological investigations 
of the spleen, MN analyses before and after splenectomy, and comparisons between MN 
frequency in peripheral blood versus bone marrow [180]. Using this classification and other 
studies to better discriminate between species of the same family or genus [175][148][174], 
we have selected species suitable for the MNE test (highlighted in Table 3). As a result, the 
species cohort decreased to 21.  
To allow logarithmic transformation, 0.5 points was added to each MNEF value (in all figures, 
the abbreviation log10 MNEF implies this addition). Correlations were done between log10 
values calculating R2 and the significance of the regression line using Microsoft Excel software 
(Microsoft Corporation, Redmond, Washington, USA). Comparative analysis was performed 
as suggest by Speakman [181]. Although the values are highly dispersed, trend lines show an 
inverse and highly significant relationship of MNEF with both body mass and maximum 
longevity (Figure 37, A and B respectively). A scatter plot of the relationship between 
maximum longevity and adult body mass for the selected species is shown in Figure 37.C. 
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Figure 37. Correlations between log10 micronucleated erythrocyte frequency (MNEF) versus log10 
body mads (BM) and log10 maximum longevity (ML) and correlation between log10 BM versus log10 
ML. In A, B, C, are reported the correlations for all species reported in Table 1, n=47. In D, E, F are 
reported the correlations for species judged suitable for the MNE test (highlighted in Table 1), n=21. 
In G, H, I are reported the correlations for species judged suitable for the MNE test (highlighted in Table 
3) with n ≥ 3, n=13. Linear regression, coefficient of determination (R2), and significance value 
(p) are shown.  
 
A second set of analysis was performed only on species without a micronucleated erythrocytes 
filtering spleen. Although the cohort size was necessarily smaller, the correlation between 
MNEF and body mass as well as that between MNEF and maximum longevity improved (Figure 
37.D and 37.E respectively). This suggests that any potential link between MNEF as a measure 
of genomic stability and body mass or maximum longevity may be partially hidden if the filter 
action of the spleen is not taken into account. 
A third set of analysis was performed only for species for which the number of replicates was 
above or equal three. In this last analysis, the significance of the relationship between body 
mass e MNEF was not abolished (Fig. 37.G); on the opposite, the significance of the 
relationship between longevity and MNEF was lost (Fig. 37.H). This analysis underline the 
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existence of a tighter relation between body mass and MNEF, in comparison to the one 
between maximum longevity and MNEF. 
4.3.2   Residuals and phylogenetically independent contrasts analyses 
In approaching the residuals and the phylogenetically independent contrasts analyses, we 
considered more relevant the issue of micronucleated erythrocytes removal by the spleen 
filtrating action than the issue of the low n value for some of the considered species. 
Consequently, to avoid performing these analyses on a too small cohort, we decided to 
eliminate the species were the spleen has a filtrating action and, at the same time, to keep in 
also species with an n < 3. Proceeding in this way, these analyses were conducted on 21 
species (see Table 3, highlighted data add ref paper). The first analysis shows the correlation 
between the residual of MNEF and the residual of body mass, in both cases controlling for 
maximum longevity (Fig. 38.A), and the correlation between the residual of MNEF and the 
residual of maximum longevity, in both cases controlling for body mass (Fig. 38.B). 
 
 
 
Figure 38. Analysis of residuals. Regression plot using the residual approach: Residual of log10 
MNEF versus residual of log10 body mass (BM) controlling for log10 maximum longevity (A); 
Residual of log10 MNEF versus residual of log10 maximum longevity (ML) controlling for log10 
body mass (B). Linear regression, coefficient of determination (R2), and significance value (p) 
are shown.  
 
Since the relationship with body mass remains significant, while that with longevity does not, 
this analysis suggests, as for the proceeding correlations, that the determinant factor is body 
mass.               
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4.4 PART III- Role of 53BP1 in chronological age 
 
4.4.1 Small increase of spontaneous 53BP1 foci in middle and old donors 
It has been showed that human fibroblasts exhibit a decline in DNA double strand breaks (DSB) 
repair pathways [182] and a gradual decline of DSB repair capacity was observed in nucleated 
peripheral blood cells of old human donors [183]. Based on these evidence, I aimed to test if 
the efficiency in sensing DNA damage and repair ability, measured by 53BP1 foci formation, is 
impaired during the aging process. To address this question, fibroblasts from three donors 
groups characterised by different chronological age were treated with a low dose of ionizing 
radiation (1 Gy). All the experiments on three donors groups were performed at the “Central 
Institute of Clinical Chemistry and Laboratory Medicine”, University of Dusseldorf. All cells 
used were at a low passage in culture, far from replicative senescence. Irradiated cells were 
allowed to recover for 2, 24, 48 and 72 hours after damage. Figure 39 shows a time-course 
analysis after 1 Gy irradiation, where the same 53BP1 foci formation kinetic was observed in 
the three donors groups (Figure 18.A), similar to the kinetic observed in the comparative 
experimental assay across the species: the 53BP1 foci formation peak, observed at 2 hours 
after damage, is followed by a gradual decline in the percentage of 53BP1 foci positive nuclei 
(Figure 39).  
A)                                                                                   B) 
 
 
Figure 39: 53BP1 foci formation kinetic in young, middle and old donors. 53BP1 formation 
was monitored from 2 up to 72h after 1 Gy irradiation. Foci were grouped in F≥1 (A) or F≥5 
(B).   
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In figure 40, a bar graph shows the percentage of 53BP1 foci recruited for each donor group 
scored, for each sample, on a total of 100 cells. Data report a small increase of 53BP1 foci 
associated to an increase of chronological age (Fig 40.B), in untreated cells although not 
significant. Noteworthy is that Kalfalah et al. [143], using the same cell strains, have reported 
a significant increase in untreated fibroblasts. The same conclusion was deduced in [157]  
A)                                                                                                B) 
        
Figure 40: 53BP1 foci distribution in young, middle and old donors. A) 53BP1 foci were scored at 2, 
24, 48 and 72 hours after damage. Cells with more than 1 focus per nucleus are represented in the 
graph. Statistical significance is referred to the increase of 53BP1 foci of treated compared to their 
respective untreated (0 h). B) 53BP1 foci/nucleus in untreated young, middle and old donors. Means 
+/- s.e.m of two independent experiments are represented in the graph. 
 
The three chronological groups don’t show any significant difference in their ability to sense 
damage (% 53BP1 foci) measured 2h after damage, at least when irradiated with low doses 
IR. Data are consistent with Kalfalah et al. [152]. Despite literature suggests a decline of the 
DNA damage repair, not significant differences were observed among young, middle or old 
donors in the present work.  
4.2.2 Absence of MN variation with chronologica age 
To assess the amount of unresolved damage in each chronological-age group after genotoxic 
stress (1 Gy irradiation dose), we scored micronuclei formation 0, 2, 24, 48 and 72 h after. 
Statistical analysis was performed comparing treated samples to untreated cells. Scoring MN 
in each experimental group did not reveal significant difference among young, middle and old 
donors, at any analysed time point.            
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4.4.3  Higher rate of DNA-SCARS in old donors 
Severe and irreparable DNA damage lesions induce cells to senescence, which is accompanied 
by persistent DNA damage foci, constitutive DDR signalling activation and chronic p53 
induction [184]. In this context, it has been recently showed that PMLnb may play a role in 
stress-induced senescence. In fact it can facilitates p53 activation, the senescence growth 
arrest [185][186] and DNA-SCARS formation, in senescent cells. As previously mentioned, 
PMLnb and 53BP1 co-localization are associated to DNA-SCARS. In order to evaluate if the 
ability to induce senescence in untreated or treated cells is impaired within aging, we scored 
the percentage of co-localization of persistent 53BP1 damage foci and PMLnb, during the 
transition to senescence after low and high doses of IR. Analysis of DNA-SCARS has been 
restricted to young and old groups, in order to reduce a possible confounding factor coming 
from the middle group of donors. First, unsynchronized fibroblast from young and old donors 
were seeded one day prior to treatment and then irradiated with increasing IR doses (1 and 
10 Gy). Treated cells were allowed to recover for 48h, time point at which cells were fixed and 
analysed. Co-localization of DNA-SCARS and PMLnb is complete 48 hours after irradiation 
[121]. 
Figure 42: Persistent 53BP1 foci/ nucleus 
increase in old donors in response to high 
doses irradiation. 53BP1 foci/nucleus were 
scored 48h after 1 and 10 Gy irradiation. 
Statistical analysis is referred to % 53BP1 
foci/nucleus in treated compared to 
respective untreated (0 Gy). Means +/- s.e.m 
of two independent experiments are 
represented in the graph. 
 
Figure 41: Absence of significant 
correlation between MN formation 
and chronological age. MN were 
scored in irradiated fibroblast from 
young, middle and old donors. 
Statistical analysis is referred to % 
MN in treated compared to 
respective untreated (0 h). Means 
+/- s.e.m of two independent 
experiments are represented in the 
graph. 
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As showed in figure 42, all proliferating cells, exposed to 1 and 10 Gy, developed persistent 
53BP1 foci as observed at 48h. The comparison of 53BP1 foci/nuclei, between young and old 
group, show a small increase of 53BP1 foci/nucleus at 1 Gy, and a higher increase at 10 Gy in 
the group of old donors. In order to define whether 53BP1 long lasting foci are associated to 
PMLnb, and therefore identified as DNA- SCARS, the rate of 53BP1 co-localized or overlapped 
to PMLnb was investigate in the same groups. As showed in figure 43.A, 10 Gy irradiation 
induces a significant increase of the % 53BP1-PMLnb co-localization. Association of 53BP1 to 
PMLnb is observed also in controls cells.  In fact, it has been showed that 53BP1 foci co-
localization to PML , in untreated cells, is  approximatively 70%, suggesting that DNA-SCARS 
or TIF in the senescent cells that are present in most normal human cell populations [121]. 
Moreover, the % of co-localization of 53BP1 foci to PMLnb per nucleus is higher, at higher 
doses, in old donors, although not significant.    
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Figure 43: DNA-SCARS increase in old donors. 53BP1 co-localization with PMLnb was 
performed in young and old donors. A) % 53BP1 colocalization-contigous to PMLnb were 
scored 48h after 1 and 10 Gy irradiation. 50 nuclei for each experimental treatment were scored. 
Significant statistical valure is referred to % 53BP1 colocalization-contigous to PMLnb per nucleus  
in treated compared to respective untreated (0 Gy). Means +/- s.e.m of two independent 
experiments are represented in the graph. 
 
 
A) B) 
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5. CONCLUSIONS 
 
Despite significant experimental support have been produced for the elaboration of theories 
which may explain the aging process and the evolution of longevity [3], aging still remains a 
fascinating field to further explore. The aim of the present work is to investigate mechanisms 
which may influence lifespan length and partially explain the exceptional longevity of some 
species, like human.  
The mammalian radiation, in evolutionary terms, is a relatively recent event; so since life on 
the planet has had the form of individual cells for the majority of the evolutionary time, it is 
plausible to hypothesize that many basic cellular mechanisms are highly conserved among 
mammals. Then, with a look at the mammalian evolutionary tree, it seems reasonable to 
investigate if conserved cellular mechanisms show some convergent adaptation to long life. 
In a comparative analysis of the evolution of longevity, together with lifespan length, 
maximum adult body size should always be taken in consideration. Both features, in fact, are 
fundamental traits which may widely vary between species [187] (see figure 44). 
 
 
 
 
Figure 44. Body size evolution in vertebrates. 
Figure adapted from [188]. Relationship 
between body mass (g) and lifespan (years) 
among 2556 vertebrates. Blue line shows the 
linear regression between log (body mass) and 
log (lifespan), R2 = 0.32. 
  
Assuming that all cells have a similar risk to accumulate mutations, larger and longer-lived 
animals should have higher risk of developing cancer than smaller and shorter-lived species. 
But, there are no scientific evidence of the existence of a relationship between the size of an 
animal and its risk of developing cancer. Consequently, a fundamental question in 
comparative biology is how very large or long-lived animals protect themselves against 
diseases (i.e. cancer development) and the accumulation of genomic damage [182].  
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The meta-analysis performed in the present work suggested a possible mechanism which may 
explain the preferential adaptation for the evolution and achievement of a large body. DNA 
damage can accumulate both in mitotic and post-mitotic tissues and dividing cells represent 
a susceptible target. Cell division, in fact, requires DNA synthesis, elevated transcription, and 
chromosome segregation. All these processes are potentially errors prone and a source of 
threats, which may impair DNA integrity. In adulthood, during the maintenance of mitotic 
tissues (gut, skin, blood, etc), but especially during development, there is the need to produce 
a certain number of cells in a given time, in order to guarantee balanced growth and tissue 
renewal. Therefore, it has been hypothesized that during the evolution of cellular 
maintenance mechanisms, time has represented an important constraint [189]. The meta-
analysis of published data, performed in the present work, demonstrated the existence of an 
inverse link between basal MNEF and species body mass; additionally none relationship to 
longevity has been identified (Figure 38). Large bodies require more cell divisions during 
development and homeostatic maintenance. Consequently, it is reasonable to propose that 
together with the evolution of large bodies there was a concurrent improvement in the 
efficiency of the mitotic apparatus. In a small comparison of six mammals it was showed, in 
fact, that the fidelity of the spindle assembly check point, a cellular mechanism ensuring 
proper alignment of chromosomes at the metaphase plate of the mitotic spindle, correlates 
strictly with species adult body mass [189].  
 
 
Figure 45. Micronucleated erythrocytes frequency (MNEF) as improper chromosome 
segregation. The meta-analysis showed a clear and inverse link between basal MNEF and 
species body mass.  
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Together with the data shown in the meta-analysis, this hypothesis suggests that spontaneous 
level of MN in circulating erythrocytes could be interpreted as a marker of improper 
chromosome segregation during erythropoiesis (an hypothesis that could be verified analyzing 
the presence of centromeres in MN), which is higher in small sized-animals (Figure 45). 
On the other hand, the capacity to repair DNA, when damaged by exogenous or endogenous 
substances or by improper transcription or duplication, might still be an important 
determinant for longevity. As time passes, healthy cells become more prone to accumulate 
mutations at DNA level, which in turn can lead to cancerous transformation or accelerated 
aging. In fact, the DNA damage accumulation theory of aging suggests that “hits” to the 
genome, acquired over time, may be responsible for the aging process [34]. Support of this 
theory comes in part from the fact that several human premature aging syndromes are 
characterized by defects in single genes, coding either for DNA repair proteins or for lamin A, 
a protein primarily involved in nuclear architecture with the capacity to influence genomic 
stability. These syndromes dramatically shorten longevity in affected patients (reviewed in 
[190]). In addition, also the hypothesis that DNA damage repair may be impaired during aging 
has several experimental support [162][163].  
53BP1 protein is a DNA damage marker and a repair orchestrator which accumulates in 
nuclear foci and activates transcription of genes involved in the cell cycle control in a p53-
dependent manner [101] in response to DSBs. Overall, 53BP1 is a fundamental protein for 
DNA damage detection and maintenance of genomic stability.  The presence of persistent 
53BP1 foci was analyzed in a large investigation of skin-derived fibroblasts from 100 human 
donors aged 20 to 90 years. A positive correlation between donor age and 53BP1 foci and a 
positive correlation between 53BP1 foci and micronuclei were observed in support of the 
concept that, inside a single species, 53BP1 represents a marker of the endured DNA damage 
[157]. Considering this last hypothesis, in the present work, an analysis of 53BP1 foci 
formation in fibroblasts from a small cohort of donors was conducted, in order to measure 
possible impairment in the repair machinery with aging. In the above mentioned study on 100 
human donors, analysis of 53BP1 endured foci was performed after an oxidative damage. 
While, the focus of the current analysis was orientated on the DNA damage answer after 
radiation-induced DSBs. The basal number of 53BP1 foci/nucleus increased by the increase of 
chronological age (although not significantly). Additionally, both young and old group of 
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donors are still able to induce DNA-SCARS, even though at different grade. Co-localization of 
53BP1 and PMLnb results increased in old donors at high irradiation doses, suggesting a small 
impairment in the repair machinery. Finally, although further investigation might be required, 
data suggest that chronological aging is associated with an increase of spontaneous 53BP1 foci 
and 53BP1 DNA-SCARS. Notwithstanding chronological aging seems to be associated to an 
increase of DNA damage SCARS, Lattanzi et al. suggested instead that the up-regulation of 
NHEJ recombination pathway in centenarians represents a reshaping of the DNA Damage 
response rather than a decline in the DNA repair capability [191]. Additionally, they showed 
that rapamycin increases 53BP1 recruitment in a prelamin-A-accumulation dependent 
manner in young, old and centenarians donors, hypothesising that these events are part of a 
defence mechanism against stress events and, therefore, may contribute to lifespan 
extension. 
Then, based on the DNA damage accumulation theory, one plausible hypothesis is that 
convergent evolution could be at play in the mechanism that protects long-lived species from 
accumulation of DNA damage. One of this possible mechanism is the efficiency in the  
detection and repair of DNA damage. In fact, identification of damage is a necessary step in 
order to proceed with repair or, if the damage is irreparable, with the induction of additional 
cellular pathways like senescence or apoptosis. The major experimental hypothesis of the 
present work aimed to test if the efficiency of DNA damage detection and repair could be a 
potential cellular determinant for the evolution of longevity in mammals. In order to test this 
latter hypothesis, the focus of the present work was the investigation of the role of 53BP1 in 
response to DBS, induced by several procedures (genotoxic treatments and IR), as a possible 
player and determinant factor to explain the wide differences in terms of longevity across five 
mammals species (mouse, dog, cow, bat, human).  
Analysis of the appearance of the number of DNA damage-induced 53BP1 foci in human cells, 
compared to other four mammal species, surprisingly showed that longer-lived species 
respond to DSB forming more of this foci. This initial finding was counterintuitive since a higher 
number of foci are generally interpreted as evidence of a greater amount of damage. 
However, using direct measurements of DNA damage such as the comet assay (Figure 28) and 
micronuclei counts (Figure 29), we report here that longevity and, to a lesser extent, adult 
body size are indeed associated with higher genomic stability. Data about foci abundance in 
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micronucleated cells suggest that the failure of the cellular mechanism responsible for MN 
production and for nuclear abnormalities is downstream  53BP1 foci formation (Figures 14 
and 15). This hypothesis was strongly confirmed by data on stable 53BP1 knockdown clones. 
In this model, reduction of 53BP1 level is associated to an evident increase of MN in treated 
cells, suggesting the direct contribution of 53BP1 in the process which ensures maintenance 
of genomic stability. 
In the present work, species with significant longevity (human and little brown bat) and 
species with a combination of moderate longevity and large adult body size (cow) showed a 
higher level of early repair measured by the comet assay. Additionally, mouse, the species in 
the present study in which short life span associates with a small body mass, shows a 
significantly higher level of micronuclei, when compared with all other longer-lived or larger 
species. Thus, analysing data under the lens “53BP1 foci abundance”, two interpretation are 
possible: 1) mouse cells, and to a lesser extent cow cells, produce fewer foci after damage 
compared with the other species;  2) little brown bat and human, the two species with the 
longest life span, show the highest level of foci both at shorter (see 5 µM ETO  treatment) and 
at longer time points (see 0.13 µM NCS treatment).  
Rodier and colleagues suggests that persistent foci (i.e., foci that have not resolved in 24 h) 
should be considered as DNA-SCARS [121], in other words foci associated to stress-induced-
senescence. Our data on PML contiguity with 53BP1 in human cells supports the proposal that 
53BP1 long lasting foci are gathered to the ability to induce senescence in the case DNA 
damage is irreparable. To further test, if the ability to induce senescence or apoptosis is also 
a determinant for lifespan length, β-galactosidase activity and AnnexinV(+) cells abundance 
were measured in human and mouse or in all the five mammalian species, respectively 
(Figures 22 and 26). These analysis confirmed that DNA damage induced senescence and 
apoptosis, in association with more proficient cell cycle checkpoints, could be an effective way 
to guarantee tissues genomic stability when multiple cellular divisions are required to provide 
sufficient tissue turnover during a long lifespan or attain a large body size. 
Taking together all these considerations, we propose that 53BP1 has a double biological 
meaning: a) early appearing foci are the sign of an active DNA damage repair and their 
abundance is related to damage detection efficiency; b) long lasting foci are a sign of residual 
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and persistent damage. Thus, as we can deduct from up-regulation of 53BP1 in longer lived 
species, both these features are potentially important in species longevity determination.  
The hypothesis that specific cellular functionalities, necessary to guarantee genomic stability, 
may be upregulated simply by increasing the abundance of key proteins is a straightforward 
one. Sulak et al., for example, have shown that the Asian and African elephants (among the 
largest but also the longed-lived mammals species), encodes up to 20 additionally gene copies 
of TP53 [188]. This ensues in an increased expression of the oncosuppressor following 
genotoxic stress and a consequent increase in apoptosis in comparison to phylogenetically 
closely related species (hyrax, aardvark, and armadillo) (Figure 44). Another example comes 
from the analysis of Parp activity: it varies more than fivefold from short lived to long-lived 
mammals. Yet, Parp protein abundance across species is not related to its activity level [88]. 
In a further analysis of proteins involved in NHEJ activation, DNA ligase IV expression was 
examined using an antibody raised against a peptide conserved between human and rodents. 
It was found that abundance for this protein is similar among human, hamster, and mouse 
cells [13].  
 When one considers these examples it appears that evolutionary changes to improve 
genomic stability driving also structural modification (which can improve protein functionality) 
or by the overexpression of key proteins involved in DNA repair, cell cycle control, induction 
of apoptosis and senescence. Although it will be difficult to disentangle the different aspects 
of these evolutionary processes, we believe that considering the role of many molecular 
mechanisms will be more informative rather than focusing on a single alteration as a driver of 
genomic stability . Albeit the investigation conducted in the present work, included a small 
number of species, selection was performed according to strict criteria which need to be 
respected for a comparative analysis: selection included species with a wide range in 
maximum life span and adult body mass, with the attempt to dissociate the potential effects 
of these two parameters on genome stability. Species longevity and body mass are known to 
correlate with each other [189] and it is reasonable to expect that they both correlate 
positively with genome stability. The following model is proposed as a possible explanation of 
the differences we observed among the species (Figure 45): 
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Figure 45: Proposed model. Red dots represent 53BP1 foci while lightning images represent DNA 
damage. See discussion for model explanation 
 
“In mammals, DNA and associated proteins (histones) are chemically equivalent and similarly 
fragile if exposed to the same amount of genotoxic damage. In a single species, 53BP1 foci 
abundance is proportional to the amount of damage. However, the differences observed in 
foci abundance among species are not due to different quantity of damage but rather to 
different ability to detect it. We suggest that foci represent a primary DNA damage response. 
Thus, within each species, an increasing amount of damage correlates with a growing number 
of foci. But, when species are compared, longer-lived or larger species induce the formation 
of a higher number of foci for a similar content of DNA damage suggesting their higher 
efficiency in the primary DNA damage response. A potential downstream consequence of this 
difference is that long-lived or larger species may be more prone to activate cell cycle arrest, 
DNA repair, apoptosis, or senescence. The choice between these options will likely depend on 
the interactions between the level of damage and other cellular and extracellular conditions.” 
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In the context of our previous observation on DNA-end binding [13], we believe that improving 
DNA damage detection could be an evolutionary conserved mechanism to provide the 
increased genomic stability required in long-lived and large species to prevent respectively 
early life tissue dysfunctions and tumors development. The relevance of this observation goes 
beyond the aging field since scientists: DNA damage foci are widely studied, in the clinical 
field, as potential markers for radiosensitivity of tumors [192] and in patients’ normal tissues  
[193]. Clinicians, therefore, will have to interpret correctly data obtained by researcher using 
different species to design the most adapt therapy for humans. 
In conclusion we propose that the evolution of longevity is the result of the concurrently 
improved efficiency in different cellular machineries and that DNA damage detection driven 
by 53BP1 is actively contributing to this improvement. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 87 
 
6. List of references 
 
[1] P. Sen, P. P. Shah, R. Nativio, and S. L. Berger, “Epigenetic Mechanisms of Longevity 
and Aging,” Cell, vol. 166, no. 4, pp. 822–839, Aug. 2016. 
[2] M. J. Rae et al., “The demographic and biomedical case for late-life interventions in 
aging.,” Sci. Transl. Med., vol. 2, no. 40, p. 40cm21, Jul. 2010. 
[3] C. López-Otín, M. A. Blasco, L. Partridge, M. Serrano, and G. Kroemer, “The hallmarks 
of aging.,” Cell, vol. 153, no. 6, pp. 1194–217, Jun. 2013. 
[4] L. HAYFLICK and P. S. MOORHEAD, “The serial cultivation of human diploid cell 
strains.,” Exp. Cell Res., vol. 25, pp. 585–621, Dec. 1961. 
[5] A. M. Olovnikov, “Telomeres, telomerase, and aging: Origin of the theory,” Exp. 
Gerontol., vol. 31, no. 4, pp. 443–448, 1996. 
[6] A. G. Bodnar, “Extension of Life-Span by Introduction of Telomerase into Normal 
Human Cells,” Science (80-. )., vol. 279, no. 5349, pp. 349–352, Jan. 1998. 
[7] M. A. Blasco, “Telomere length, stem cells and aging,” Nat. Chem. Biol., vol. 3, no. 10, 
pp. 640–649, Oct. 2007. 
[8] M. Armanios and E. H. Blackburn, “The telomere syndromes,” Nat. Rev. Genet., vol. 
13, no. 10, pp. 693–704, Sep. 2012. 
[9] M. Armanios, J. K. Alder, E. M. Parry, B. Karim, M. A. Strong, and C. W. Greider, “Short 
Telomeres are Sufficient to Cause the Degenerative Defects Associated with Aging,” 
Am. J. Hum. Genet., vol. 85, no. 6, pp. 823–832, Dec. 2009. 
[10] K. L. Rudolph et al., “Longevity, stress response, and cancer in aging telomerase-
deficient mice.,” Cell, vol. 96, no. 5, pp. 701–12, Mar. 1999. 
[11] A. Tomás-Loba et al., “Telomerase Reverse Transcriptase Delays Aging in Cancer-
Resistant Mice,” Cell, vol. 135, no. 4, pp. 609–622, Nov. 2008. 
[12] A. Seluanov et al., “Telomerase activity coevolves with body mass not lifespan,” Aging 
List of references 
88 
 
Cell, vol. 6, no. 1, pp. 45–52, Feb. 2007. 
[13] A. Lorenzini et al., “Significant correlation of species longevity with DNA double strand 
break recognition but not with telomere length.,” Mech. Ageing Dev., vol. 130, no. 11–
12, pp. 784–92, Nov. 2009. 
[14] N. M. V Gomes et al., “Comparative biology of mammalian telomeres: hypotheses on 
ancestral states and the roles of telomeres in longevity determination.,” Aging Cell, 
vol. 10, no. 5, pp. 761–8, Oct. 2011. 
[15] J. A. Stuart et al., “A comparative cellular and molecular biology of longevity 
database.,” Age (Dordr)., vol. 35, no. 5, pp. 1937–47, Oct. 2013. 
[16] R. Peto, “Quantitative implications of the approximate irrelevance of mammalian 
body size and lifespan to lifelong cancer risk.,” Philos. Trans. R. Soc. Lond. B. Biol. Sci., 
vol. 370, no. 1673, p. 20150198, Jul. 2015. 
[17] C. H. Waddington, “The Epigenotype,” Int. J. Epidemiol., vol. 41, no. 1, pp. 10–13, Feb. 
2012. 
[18] M. F. Fraga and M. Esteller, “Epigenetics and aging: the targets and the marks,” Trends 
Genet., vol. 23, no. 8, pp. 413–418, Aug. 2007. 
[19] S. Han and A. Brunet, “Histone methylation makes its mark on longevity,” Trends Cell 
Biol., vol. 22, no. 1, pp. 42–49, Jan. 2012. 
[20] B. A. Benayoun, E. A. Pollina, and A. Brunet, “Epigenetic regulation of ageing: linking 
environmental inputs to genomic stability,” Nat. Rev. Mol. Cell Biol., vol. 16, no. 10, 
pp. 593–610, Sep. 2015. 
[21] E. A. Pollina and A. Brunet, “Epigenetic regulation of aging stem cells.,” Oncogene, vol. 
30, no. 28, pp. 3105–26, Jul. 2011. 
[22] L. Liu et al., “Chromatin modifications as determinants of muscle stem cell quiescence 
and chronological aging.,” Cell Rep., vol. 4, no. 1, pp. 189–204, Jul. 2013. 
[23] A. D. Goldberg et al., “Epigenetics: A Landscape Takes Shape,” Cell, vol. 128, no. 4, pp. 
635–638, Feb. 2007. 
List of references 
89 
 
[24] Y. Kanfi et al., “SIRT6 protects against pathological damage caused by diet-induced 
obesity,” Aging Cell, vol. 9, no. 2, pp. 162–173, Apr. 2010. 
[25] R. Mostoslavsky et al., “Genomic Instability and Aging-like Phenotype in the Absence 
of Mammalian SIRT6,” Cell, vol. 124, no. 2, pp. 315–329, Jan. 2006. 
[26] L. Lapasset et al., “Rejuvenating senescent and centenarian human cells by 
reprogramming through the pluripotent state.,” Genes Dev., vol. 25, no. 21, pp. 2248–
53, Nov. 2011. 
[27] S. Mahmoudi and A. Brunet, “Aging and reprogramming: a two-way street.,” Curr. 
Opin. Cell Biol., vol. 24, no. 6, pp. 744–56, Dec. 2012. 
[28] G.-H. Liu et al., “Recapitulation of premature ageing with iPSCs from Hutchinson-
Gilford progeria syndrome.,” Nature, vol. 472, no. 7342, pp. 221–5, Apr. 2011. 
[29] T. A. Rando and H. Y. Chang, “Aging, rejuvenation, and epigenetic reprogramming: 
resetting the aging clock.,” Cell, vol. 148, no. 1–2, pp. 46–57, Jan. 2012. 
[30] A. Ocampo et al., “In Vivo Amelioration of Age-Associated Hallmarks by Partial 
Reprogramming.,” Cell, vol. 167, no. 7, p. 1719–1733.e12, Dec. 2016. 
[31] J. H. J. Hoeijmakers, “DNA damage, aging, and cancer.,” N. Engl. J. Med., vol. 361, no. 
15, pp. 1475–85, Oct. 2009. 
[32] S. Q. Gregg et al., “A mouse model of accelerated liver aging caused by a defect in 
DNA repair,” Hepatology, vol. 55, no. 2, pp. 609–621, Feb. 2012. 
[33] M. Murga et al., “A mouse model of ATR-Seckel shows embryonic replicative stress 
and accelerated aging,” Nat. Genet., vol. 41, no. 8, pp. 891–898, Aug. 2009. 
[34] A. A. Moskalev et al., “The role of DNA damage and repair in aging through the prism 
of Koch-like criteria.,” Ageing Res. Rev., vol. 12, no. 2, pp. 661–84, Mar. 2013. 
[35] F. Faggioli, T. Wang, J. Vijg, and C. Montagna, “Chromosome-specific accumulation of 
aneuploidy in the aging mouse brain.,” Hum. Mol. Genet., vol. 21, no. 24, pp. 5246–53, 
Dec. 2012. 
[36] L. A. Forsberg et al., “Age-related somatic structural changes in the nuclear genome of 
List of references 
90 
 
human blood cells,” Am. J. Hum. Genet., vol. 90, no. 2, pp. 217–228, Feb. 2012. 
[37] A. Musacchio and E. D. Salmon, “The spindle-assembly checkpoint in space and time.,” 
Nat. Rev. Mol. Cell Biol., vol. 8, no. 5, pp. 379–93, May 2007. 
[38] D. J. Baker et al., “BubR1 insufficiency causes early onset of aging-associated 
phenotypes and infertility in mice.,” Nat. Genet., vol. 36, no. 7, pp. 744–9, Jul. 2004. 
[39] D. J. Baker et al., “Increased expression of BubR1 protects against aneuploidy and 
cancer and extends healthy lifespan,” Nat. Cell Biol., vol. 15, no. 1, pp. 96–102, Dec. 
2012. 
[40] A. Kowald and T. B. Kirkwood, “A network theory of ageing: the interactions of 
defective mitochondria, aberrant proteins, free radicals and scavengers in the ageing 
process.,” Mutat. Res., vol. 316, no. 5–6, pp. 209–36, May 1996. 
[41] V. N. Gladyshev, “The origin of aging: imperfectness-driven non-random damage 
defines the aging process and control of lifespan.,” Trends Genet., vol. 29, no. 9, pp. 
506–12, Sep. 2013. 
[42] O. R. Jones et al., “Diversity of ageing across the tree of life,” Nature, vol. 505, no. 
7482, pp. 169–173, Dec. 2013. 
[43] T. Bilinski, A. Bylak, and R. Zadrag-Tecza, “Principles of alternative gerontology.,” 
Aging (Albany. NY)., vol. 8, no. 4, pp. 589–602, Apr. 2016. 
[44] D. HARMAN, “Aging: a theory based on free radical and radiation chemistry.,” J. 
Gerontol., vol. 11, no. 3, pp. 298–300, Jul. 1956. 
[45] K. B. Beckman and B. N. Ames, “The free radical theory of aging matures.,” Physiol. 
Rev., vol. 78, no. 2, pp. 547–81, Apr. 1998. 
[46] S. Miwa, K. Riyahi, L. Partridge, and M. D. Brand, “Lack of correlation between 
mitochondrial reactive oxygen species production and life span in Drosophila.,” Ann. 
N. Y. Acad. Sci., vol. 1019, no. 1, pp. 388–91, Jun. 2004. 
[47] A. K. BRUNET ROSSINNI, “Testing the Free Radical Theory of Aging in Bats,” Ann. N. Y. 
Acad. Sci., vol. 1019, no. 1, pp. 506–508, Jun. 2004. 
List of references 
91 
 
[48] T. R. Golden, D. A. Hinerfeld, and S. Melov, “Oxidative stress and aging: beyond 
correlation.,” Aging Cell, vol. 1, no. 2, pp. 117–23, Dec. 2002. 
[49] T. T. Huang, E. J. Carlson, A. M. Gillespie, Y. Shi, and C. J. Epstein, “Ubiquitous 
overexpression of CuZn superoxide dismutase does not extend life span in mice.,” J. 
Gerontol. A. Biol. Sci. Med. Sci., vol. 55, no. 1, pp. B5-9, Jan. 2000. 
[50] E. Dufour and N.-G. Larsson, “Understanding aging: revealing order out of chaos.,” 
Biochim. Biophys. Acta, vol. 1658, no. 1–2, pp. 122–32, Jul. 2004. 
[51] V. N. Gladyshev, “The origin of aging: imperfectness-driven non-random damage 
defines the aging process and control of lifespan.,” Trends Genet., vol. 29, no. 9, pp. 
506–12, Sep. 2013. 
[52] G. FAILLA, “The aging process and cancerogenesis.,” Ann. N. Y. Acad. Sci., vol. 71, no. 
6, pp. 1124–40, Sep. 1958. 
[53] G. M. Martin, A. C. Smith, D. J. Ketterer, C. E. Ogburn, and C. M. Disteche, “Increased 
chromosomal aberrations in first metaphases of cells isolated from the kidneys of 
aged mice.,” Isr. J. Med. Sci., vol. 21, no. 3, pp. 296–301, Mar. 1985. 
[54] T. Lu et al., “Gene regulation and DNA damage in the ageing human brain.,” Nature, 
vol. 429, no. 6994, pp. 883–91, Jun. 2004. 
[55] M. Hyun, J. Lee, K. Lee, A. May, V. A. Bohr, and B. Ahn, “Longevity and resistance to 
stress correlate with DNA repair capacity in Caenorhabditis elegans.,” Nucleic Acids 
Res., vol. 36, no. 4, pp. 1380–9, Mar. 2008. 
[56] G. M. Martin and J. Oshima, “Lessons from human progeroid syndromes.,” Nature, 
vol. 408, no. 6809, pp. 263–6, Nov. 2000. 
[57] A. A. Freitas, O. Vasieva, and J. P. de Magalhães, “A data mining approach for 
classifying DNA repair genes into ageing-related or non-ageing-related.,” BMC 
Genomics, vol. 12, no. 1, p. 27, Jan. 2011. 
[58] R. Zoncu, A. Efeyan, and D. M. Sabatini, “mTOR: from growth signal integration to 
cancer, diabetes and ageing.,” Nat. Rev. Mol. Cell Biol., vol. 12, no. 1, pp. 21–35, Jan. 
2011. 
List of references 
92 
 
[59] T. Misteli and E. Soutoglou, “The emerging role of nuclear architecture in DNA repair 
and genome maintenance,” Nat. Rev. Mol. Cell Biol., vol. 10, no. 4, pp. 243–254, Apr. 
2009. 
[60] R. D. Kornberg, “Structure of Chromatin,” Annu. Rev. Biochem., vol. 46, no. 1, pp. 931–
954, Jun. 1977. 
[61] M. Kulis and M. Esteller, “DNA Methylation and Cancer,” in Advances in genetics, vol. 
70, 2010, pp. 27–56. 
[62] T. Kouzarides, “Chromatin Modifications and Their Function,” Cell, vol. 128, no. 4, pp. 
693–705, Feb. 2007. 
[63] E. P. Rogakou, D. R. Pilch, A. H. Orr, V. S. Ivanova, and W. M. Bonner, “DNA double-
stranded breaks induce histone H2AX phosphorylation on serine 139.,” J. Biol. Chem., 
vol. 273, no. 10, pp. 5858–68, Mar. 1998. 
[64] S. E. Polo and S. P. Jackson, “Dynamics of DNA damage response proteins at DNA 
breaks: a focus on protein modifications.,” Genes Dev., vol. 25, no. 5, pp. 409–33, Mar. 
2011. 
[65] S. Panier and S. J. Boulton, “Double-strand break repair: 53BP1 comes into focus.,” 
Nat. Rev. Mol. Cell Biol., vol. 15, no. 1, pp. 7–18, Jan. 2014. 
[66] C. B. Bennett, A. L. Lewis, K. K. Baldwin, and M. A. Resnick, “Lethality induced by a 
single site-specific double-strand break in a dispensable yeast plasmid.,” Proc. Natl. 
Acad. Sci. U. S. A., vol. 90, no. 12, pp. 5613–7, Jun. 1993. 
[67] L. L. Sandell and V. A. Zakian, “Loss of a yeast telomere: arrest, recovery, and 
chromosome loss.,” Cell, vol. 75, no. 4, pp. 729–39, Nov. 1993. 
[68] M. R. Lieber, “The mechanism of double-strand DNA break repair by the 
nonhomologous DNA end-joining pathway.,” Annu. Rev. Biochem., vol. 79, no. 1, pp. 
181–211, Jun. 2010. 
[69] A. Kakarougkas and P. A. Jeggo, “DNA DSB repair pathway choice: an orchestrated 
handover mechanism.,” Br. J. Radiol., vol. 87, no. 1035, p. 20130685, Mar. 2014. 
List of references 
93 
 
[70] K. Rothkamm, I. Krüger, L. H. Thompson, and M. Löbrich, “Pathways of DNA double-
strand break repair during the mammalian cell cycle.,” Mol. Cell. Biol., vol. 23, no. 16, 
pp. 5706–15, Aug. 2003. 
[71] Z. MAO, M. BOZZELLA, A. SELUANOV, and V. GORBUNOVA, “Comparison of 
nonhomologous end joining and homologous recombination in human cells,” DNA 
Repair (Amst)., vol. 7, no. 10, pp. 1765–1771, Oct. 2008. 
[72] M. R. Lieber, “The Mechanism of Double-Strand DNA Break Repair by the 
Nonhomologous DNA End-Joining Pathway,” Annu. Rev. Biochem., vol. 79, no. 1, pp. 
181–211, Jun. 2010. 
[73] M. McVey and S. E. Lee, “MMEJ repair of double-strand breaks (director’s cut): 
deleted sequences and alternative endings,” Trends Genet., vol. 24, no. 11, pp. 529–
538, Nov. 2008. 
[74] A. Decottignies, “Alternative end-joining mechanisms: a historical perspective,” Front. 
Genet., vol. 4, p. 48, 2013. 
[75] M. Wang et al., “PARP-1 and Ku compete for repair of DNA double strand breaks by 
distinct NHEJ pathways,” Nucleic Acids Res., vol. 34, no. 21, pp. 6170–6182, Oct. 2006. 
[76] J. Della-Maria et al., “Human Mre11/Human Rad50/Nbs1 and DNA Ligase III /XRCC1 
Protein Complexes Act Together in an Alternative Nonhomologous End Joining 
Pathway,” J. Biol. Chem., vol. 286, no. 39, pp. 33845–33853, Sep. 2011. 
[77] H. Wang et al., “DNA Ligase III as a Candidate Component of Backup Pathways of 
Nonhomologous End Joining,” Cancer Res., vol. 65, no. 10, pp. 4020–4030, May 2005. 
[78] M. Audebert, B. Salles, and P. Calsou, “Involvement of Poly(ADP-ribose) Polymerase-1 
and XRCC1/DNA Ligase III in an Alternative Route for DNA Double-strand Breaks 
Rejoining,” J. Biol. Chem., vol. 279, no. 53, pp. 55117–55126, Dec. 2004. 
[79] L. N. Truong et al., “Microhomology-mediated End Joining and Homologous 
Recombination share the initial end resection step to repair DNA double-strand 
breaks in mammalian cells,” Proc. Natl. Acad. Sci., vol. 110, no. 19, pp. 7720–7725, 
May 2013. 
List of references 
94 
 
[80] Z. Mao et al., “SIRT6 Promotes DNA Repair Under Stress by Activating PARP1,” Science 
(80-. )., vol. 332, no. 6036, pp. 1443–1446, Jun. 2011. 
[81] J. Oshima, S. Huang, C. Pae, J. Campisi, and R. H. Schiestl, “Lack of WRN results in 
extensive deletion at nonhomologous joining ends.,” Cancer Res., vol. 62, no. 2, pp. 
547–51, Jan. 2002. 
[82] J. R. Walker, R. A. Corpina, and J. Goldberg, “Structure of the Ku heterodimer bound to 
DNA and its implications for double-strand break repair.,” Nature, vol. 412, no. 6847, 
pp. 607–14, Aug. 2001. 
[83] P. Grob et al., “Electron microscopy visualization of DNA–protein complexes formed 
by Ku and DNA ligase IV,” DNA Repair (Amst)., vol. 11, no. 1, pp. 74–81, Jan. 2012. 
[84] M. B. Kastan and D. S. Lim, “The many substrates and functions of ATM.,” Nat. Rev. 
Mol. Cell Biol., vol. 1, no. 3, pp. 179–86, Dec. 2000. 
[85] I. M. Ward, K. Minn, K. G. Jorda, and J. Chen, “Accumulation of checkpoint protein 
53BP1 at DNA breaks involves its binding to phosphorylated histone H2AX.,” J. Biol. 
Chem., vol. 278, no. 22, pp. 19579–82, May 2003. 
[86] S. J. Collis, T. L. DeWeese, P. A. Jeggo, and A. R. Parker, “The life and death of DNA-
PK.,” Oncogene, vol. 24, no. 6, pp. 949–61, Feb. 2005. 
[87] G. J. Williams, M. Hammel, S. K. Radhakrishnan, D. Ramsden, S. P. Lees-Miller, and J. 
A. Tainer, “Structural insights into NHEJ: building up an integrated picture of the 
dynamic DSB repair super complex, one component and interaction at a time.,” DNA 
Repair (Amst)., vol. 17, pp. 110–20, May 2014. 
[88] R. C. Getts and T. D. Stamato, “Absence of a Ku-like DNA end binding activity in the xrs 
double-strand DNA repair-deficient mutant.,” J. Biol. Chem., vol. 269, no. 23, pp. 
15981–4, Jun. 1994. 
[89] K. Grube and A. Bürkle, “Poly(ADP-ribose) polymerase activity in mononuclear 
leukocytes of 13 mammalian species correlates with species-specific life span.,” Proc. 
Natl. Acad. Sci. U. S. A., vol. 89, no. 24, pp. 11759–63, Dec. 1992. 
[90] R. W. Hart and R. B. Setlow, “Correlation between deoxyribonucleic acid excision-
List of references 
95 
 
repair and life-span in a number of mammalian species.,” Proc. Natl. Acad. Sci. U. S. 
A., vol. 71, no. 6, pp. 2169–73, Jun. 1974. 
[91] G. A. Cortopassi and E. Wang, “There is substantial agreement among interspecies 
estimates of DNA repair activity.,” Mech. Ageing Dev., vol. 91, no. 3, pp. 211–8, Nov. 
1996. 
[92] D. E. Promislow, “DNA repair and the evolution of longevity: a critical analysis.,” J. 
Theor. Biol., vol. 170, no. 3, pp. 291–300, Oct. 1994. 
[93] Y. Gu et al., “Growth retardation and leaky SCID phenotype of Ku70-deficient mice.,” 
Immunity, vol. 7, no. 5, pp. 653–65, Nov. 1997. 
[94] H. Vogel, D. S. Lim, G. Karsenty, M. Finegold, and P. Hasty, “Deletion of Ku86 causes 
early onset of senescence in mice.,” Proc. Natl. Acad. Sci. U. S. A., vol. 96, no. 19, pp. 
10770–5, Sep. 1999. 
[95] R. A. Busuttil et al., “Effect of Ku80 Deficiency on Mutation Frequencies and Spectra at 
a LacZ Reporter Locus in Mouse Tissues and Cells,” PLoS One, vol. 3, no. 10, p. e3458, 
Oct. 2008. 
[96] H. Li, H. Vogel, V. B. Holcomb, Y. Gu, and P. Hasty, “Deletion of Ku70, Ku80, or Both 
Causes Early Aging without Substantially Increased Cancer,” Mol. Cell. Biol., vol. 27, 
no. 23, pp. 8205–8214, Dec. 2007. 
[97] A. Ozgenc and L. A. Loeb, “Current advances in unraveling the function of the Werner 
syndrome protein,” Mutat. Res. Mol. Mech. Mutagen., vol. 577, no. 1–2, pp. 237–251, 
Sep. 2005. 
[98] A. Vaidya, Z. Mao, X. Tian, B. Spencer, A. Seluanov, and V. Gorbunova, “Knock-in 
reporter mice demonstrate that DNA repair by non-homologous end joining declines 
with age.,” PLoS Genet., vol. 10, no. 7, p. e1004511, Jul. 2014. 
[99] J. E. FitzGerald, M. Grenon, and N. F. Lowndes, “53BP1: function and mechanisms of 
focal recruitment,” Biochem. Soc. Trans., vol. 37, no. 4, 2009. 
[100] K. Iwabuchi, P. L. Bartel, B. Li, R. Marraccino, and S. Fields, “Two cellular proteins that 
bind to wild-type but not mutant p53.,” Proc. Natl. Acad. Sci. U. S. A., vol. 91, no. 13, 
List of references 
96 
 
pp. 6098–102, Jun. 1994. 
[101] R. Cuella-Martin, C. Oliveira, H. E. Lockstone, S. Snellenberg, N. Grolmusova, and J. R. 
Chapman, “53BP1 Integrates DNA Repair and p53-Dependent Cell Fate Decisions via 
Distinct Mechanisms.,” Mol. Cell, vol. 64, no. 1, pp. 51–64, Oct. 2016. 
[102] S. Difilippantonio et al., “53BP1 facilitates long-range DNA end-joining during V(D)J 
recombination.,” Nature, vol. 456, no. 7221, pp. 529–33, Nov. 2008. 
[103] J. P. Manis, J. C. Morales, Z. Xia, J. L. Kutok, F. W. Alt, and P. B. Carpenter, “53BP1 links 
DNA damage-response pathways to immunoglobulin heavy chain class-switch 
recombination,” Nat. Immunol., vol. 5, no. 5, pp. 481–487, May 2004. 
[104] I. M. Ward et al., “53BP1 is required for class switch recombination,” J. Cell Biol., vol. 
165, no. 4, pp. 459–464, May 2004. 
[105] J. P. Manis, J. C. Morales, Z. Xia, J. L. Kutok, F. W. Alt, and P. B. Carpenter, “53BP1 links 
DNA damage-response pathways to immunoglobulin heavy chain class-switch 
recombination.,” Nat. Immunol., vol. 5, no. 5, pp. 481–7, May 2004. 
[106] A. Fradet-Turcotte et al., “53BP1 is a reader of the DNA-damage-induced H2A Lys 15 
ubiquitin mark.,” Nature, vol. 499, no. 7456, pp. 50–4, Jul. 2013. 
[107] H. Pei et al., “MMSET regulates histone H4K20 methylation and 53BP1 accumulation 
at DNA damage sites.,” Nature, vol. 470, no. 7332, pp. 124–8, Feb. 2011. 
[108] J. C. Morales et al., “53BP1 and p53 synergize to suppress genomic instability and 
lymphomagenesis.,” Proc. Natl. Acad. Sci. U. S. A., vol. 103, no. 9, pp. 3310–5, Feb. 
2006. 
[109] I. M. Ward et al., “53BP1 Cooperates with p53 and Functions as a Haploinsufficient 
Tumor Suppressor in Mice,” Mol. Cell. Biol., vol. 25, no. 22, pp. 10079–10086, Nov. 
2005. 
[110] I. M. Ward, K. Minn, J. van Deursen, and J. Chen, “p53 Binding protein 53BP1 is 
required for DNA damage responses and tumor suppression in mice.,” Mol. Cell. Biol., 
vol. 23, no. 7, pp. 2556–63, Apr. 2003. 
List of references 
97 
 
[111] L. B. Schultz, N. H. Chehab, A. Malikzay, and T. D. Halazonetis, “p53 binding protein 1 
(53BP1) is an early participant in the cellular response to DNA double-strand breaks.,” 
J. Cell Biol., vol. 151, no. 7, pp. 1381–90, Dec. 2000. 
[112] T. Nikolova et al., “The γH2AX assay for genotoxic and nongenotoxic agents: 
comparison of H2AX phosphorylation with cell death response.,” Toxicol. Sci., vol. 140, 
no. 1, pp. 103–17, Jul. 2014. 
[113] R. A. DiTullio et al., “53BP1 functions in an ATM-dependent checkpoint pathway that 
is constitutively activated in human cancer.,” Nat. Cell Biol., vol. 4, no. 12, pp. 998–
1002, Dec. 2002. 
[114] E. Marková, N. Schultz, and I. Y. Belyaev, “Kinetics and dose-response of residual 
53BP1/gamma-H2AX foci: co-localization, relationship with DSB repair and clonogenic 
survival.,” Int. J. Radiat. Biol., vol. 83, no. 5, pp. 319–29, May 2007. 
[115] M. Podhorecka, A. Skladanowski, and P. Bozko, “H2AX Phosphorylation: Its Role in 
DNA Damage Response and Cancer Therapy,” J. Nucleic Acids, vol. 2010, pp. 1–9, Aug. 
2010. 
[116] U. Herbig, M. Ferreira, L. Condel, D. Carey, and J. M. Sedivy, “Cellular senescence in 
aging primates.,” Science, vol. 311, no. 5765, p. 1257, Mar. 2006. 
[117] R. Carbone, M. Pearson, S. Minucci, and P. G. Pelicci, “PML NBs associate with the 
hMre11 complex and p53 at sites of irradiation induced DNA damage.,” Oncogene, 
vol. 21, no. 11, pp. 1633–40, Mar. 2002. 
[118] Z.-X. Xu, A. Timanova-Atanasova, R.-X. Zhao, and K.-S. Chang, “PML colocalizes with 
and stabilizes the DNA damage response protein TopBP1.,” Mol. Cell. Biol., vol. 23, no. 
12, pp. 4247–56, Jun. 2003. 
[119] N. Stuurman, A. M. Meijne, A. J. van der Pol, L. de Jong, R. van Driel, and J. van 
Renswoude, “The nuclear matrix from cells of different origin. Evidence for a common 
set of matrix proteins.,” J. Biol. Chem., vol. 265, no. 10, pp. 5460–5, Apr. 1990. 
[120] R. Bernardi and P. P. Pandolfi, “Structure, dynamics and functions of promyelocytic 
leukaemia nuclear bodies,” Nat. Rev. Mol. Cell Biol., vol. 8, no. 12, pp. 1006–1016, 
List of references 
98 
 
Dec. 2007. 
[121] F. Rodier et al., “DNA-SCARS: distinct nuclear structures that sustain damage-induced 
senescence growth arrest and inflammatory cytokine secretion.,” J. Cell Sci., vol. 124, 
no. Pt 1, pp. 68–81, Jan. 2011. 
[122] F. Rodier et al., “Persistent DNA damage signalling triggers senescence-associated 
inflammatory cytokine secretion.,” Nat. Cell Biol., vol. 11, no. 8, pp. 973–9, Aug. 2009. 
[123] C. Rosefort, E. Fauth, and H. Zankl, “Micronuclei induced by aneugens and clastogens 
in mononucleate and binucleate cells using the cytokinesis block assay.,” 
Mutagenesis, vol. 19, no. 4, pp. 277–84, Jul. 2004. 
[124] S. Sellappa, M. Balakrishnan, S. Raman, and S. Palanisamy, “Induction of micronuclei 
in buccal mucosa on chewing a mixture of betel leaf, areca nut and tobacco.,” J. Oral 
Sci., vol. 51, no. 2, pp. 289–92, Jun. 2009. 
[125] O. Torres-Bugarín, R. Covarrubias-Bugarín, A. L. Zamora-Perez, B. M. G. Torres-
Mendoza, M. García-Ulloa, and F. G. Martínez-Sandoval, “Anabolic androgenic 
steroids induce micronuclei in buccal mucosa cells of bodybuilders.,” Br. J. Sports 
Med., vol. 41, no. 9, p. 592–6; discussion 596, Sep. 2007. 
[126] H. Tinwell and J. Ashby, “Micronucleus morphology as a means to distinguish 
aneugens and clastogens in the mouse bone marrow micronucleus assay.,” 
Mutagenesis, vol. 6, no. 3, pp. 193–8, May 1991. 
[127] P. Thomas and M. Fenech, “Cytokinesis-block micronucleus cytome assay in 
lymphocytes.,” Methods Mol. Biol., vol. 682, pp. 217–34, 2011. 
[128] M. Fenech and A. A. Morley, “Measurement of micronuclei in lymphocytes.,” Mutat. 
Res., vol. 147, no. 1–2, pp. 29–36. 
[129] K. Rothkamm, S. Barnard, J. Moquet, M. Ellender, Z. Rana, and S. Burdak-Rothkamm, 
“DNA damage foci: Meaning and significance.,” Environ. Mol. Mutagen., vol. 56, no. 6, 
pp. 491–504, Jul. 2015. 
[130] N. Dimitrova, Y.-C. M. Chen, D. L. Spector, and T. de Lange, “53BP1 promotes non-
homologous end joining of telomeres by increasing chromatin mobility.,” Nature, vol. 
List of references 
99 
 
456, no. 7221, pp. 524–8, Nov. 2008. 
[131] O. Fernandez-Capetillo et al., “DNA damage-induced G2-M checkpoint activation by 
histone H2AX and 53BP1.,” Nat. Cell Biol., vol. 4, no. 12, pp. 993–7, Dec. 2002. 
[132] B. Wang, S. Matsuoka, P. B. Carpenter, and S. J. Elledge, “53BP1, a mediator of the 
DNA damage checkpoint.,” Science, vol. 298, no. 5597, pp. 1435–8, Nov. 2002. 
[133] R. Cescutti, S. Negrini, M. Kohzaki, and T. D. Halazonetis, “TopBP1 functions with 
53BP1 in the G1 DNA damage checkpoint,” EMBO J., vol. 29, no. 21, pp. 3723–3732, 
Nov. 2010. 
[134] L. S. Fink et al., “53BP1 contributes to a robust genomic stability in human 
fibroblasts.,” Aging (Albany. NY)., vol. 3, no. 9, pp. 836–45, Sep. 2011. 
[135] S. Soubeyrand, L. Pope, and R. J. G. Haché, “Topoisomerase IIalpha-dependent 
induction of a persistent DNA damage response in response to transient etoposide 
exposure.,” Mol. Oncol., vol. 4, no. 1, pp. 38–51, Feb. 2010. 
[136] I. H. Goldberg, “Free radical mechanisms in neocarzinostatin-induced DNA damage.,” 
Free Radic. Biol. Med., vol. 3, no. 1, pp. 41–54, 1987. 
[137] L. Dostál, W. M. Kohler, J. E. Penner-Hahn, R. A. Miller, and C. A. Fierke, “Fibroblasts 
from long-lived rodent species exclude cadmium.,” J. Gerontol. A. Biol. Sci. Med. Sci., 
vol. 70, no. 1, pp. 10–9, Jan. 2015. 
[138] D. G. Gibson et al., “Creation of a bacterial cell controlled by a chemically synthesized 
genome.,” Science, vol. 329, no. 5987, pp. 52–6, Jul. 2010. 
[139] A. Bürkle, “In memoriam Bernard Strehler--genomic instability in ageing: a persistent 
challenge.,” Mech. Ageing Dev., vol. 123, no. 8, pp. 899–906, Apr. 2002. 
[140] M. Soffritti et al., “Life-span carcinogenicity studies on Sprague-Dawley rats exposed 
to γ-radiation: design of the project and report on the tumor occurrence after post-
natal radiation exposure (6 weeks of age) delivered in a single acute exposure.,” Am. J. 
Ind. Med., vol. 58, no. 1, pp. 46–60, Jan. 2015. 
[141] R. D. Wood, M. Mitchell, and T. Lindahl, “Human DNA repair genes, 2005.,” Mutat. 
List of references 
100 
 
Res., vol. 577, no. 1–2, pp. 275–83, Sep. 2005. 
[142] A. Kaya, A. V. Lobanov, and V. N. Gladyshev, “Evidence that mutation accumulation 
does not cause aging in Saccharomyces cerevisiae,” Aging Cell, vol. 14, no. 3, pp. 366–
371, Jun. 2015. 
[143] J. P. de Magalhães, J. Costa, and G. M. Church, “An analysis of the relationship 
between metabolism, developmental schedules, and longevity using phylogenetic 
independent contrasts.,” J. Gerontol. A. Biol. Sci. Med. Sci., vol. 62, no. 2, pp. 149–60, 
Feb. 2007. 
[144] A. Lorenzini, T. Stamato, and C. Sell, “The disposable soma theory revisited: time as a 
resource in the theories of aging.,” Cell Cycle, vol. 10, no. 22, pp. 3853–6, Nov. 2011. 
[145] R. Tacutu et al., “Human Ageing Genomic Resources: Integrated databases and tools 
for the biology and genetics of ageing,” Nucleic Acids Res., vol. 41, no. D1, pp. D1027–
D1033, Jan. 2013. 
[146] S. N. Austad, “Comparative Biology of Aging,” Journals Gerontol. Ser. A Biol. Sci. Med. 
Sci., vol. 64A, no. 2, pp. 199–201, Feb. 2009. 
[147] S. Bonassi et al., “The HUman MicroNucleus project on eXfoLiated buccal cells 
(HUMN(XL)): the role of life-style, host factors, occupational exposures, health status, 
and assay protocol.,” Mutat. Res., vol. 728, no. 3, pp. 88–97, Nov. 2011. 
[148] L. Abramsson-Zetterberg, J. Grawé, and G. Zetterberg, “Spontaneous and radiation-
induced micronuclei in erythrocytes from four species of wild rodents: a comparison 
with CBA mice.,” Mutat. Res., vol. 393, no. 1–2, pp. 55–71, Sep. 1997. 
[149] W. Schmid, “The micronucleus test.,” Mutat. Res., vol. 31, no. 1, pp. 9–15, Feb. 1975. 
[150] G. Krishna and M. Hayashi, “In vivo rodent micronucleus assay: protocol, conduct and 
data interpretation.,” Mutat. Res., vol. 455, no. 1–2, pp. 155–66, Nov. 2000. 
[151] R. Schlegel and J. T. MacGregor, “The persistence of micronuclei in peripheral blood 
erythrocytes: detection of chronic chromosome breakage in mice.,” Mutat. Res., vol. 
104, no. 6, pp. 367–9, Jul. 1982. 
List of references 
101 
 
[152] F. Kalfalah et al., “Structural chromosome abnormalities, increased DNA strand breaks 
and DNA strand break repair deficiency in dermal fibroblasts from old female human 
donors.,” Aging (Albany. NY)., vol. 7, no. 2, pp. 110–22, Feb. 2015. 
[153] J. Tigges et al., “The hallmarks of fibroblast ageing.,” Mech. Ageing Dev., vol. 138, pp. 
26–44, Jun. 2014. 
[154] D. M. Waldera Lupa et al., “Characterization of Skin Aging-Associated Secreted 
Proteins (SAASP) Produced by Dermal Fibroblasts Isolated from Intrinsically Aged 
Human Skin.,” J. Invest. Dermatol., vol. 135, no. 8, pp. 1954–68, Aug. 2015. 
[155] H. Takai et al., “DNA damage foci at dysfunctional telomeres.,” Curr. Biol., vol. 13, no. 
17, pp. 1549–56, Sep. 2003. 
[156] B. E. Peace and P. Succop, “Spontaneous micronucleus frequency and age: what are 
normal values?,” Mutat. Res., vol. 425, no. 2, pp. 225–30, Apr. 1999. 
[157] M. E. C. Waaijer et al., “DNA damage markers in dermal fibroblasts in vitro reflect 
chronological donor age.,” Aging (Albany. NY)., vol. 8, no. 1, pp. 147–157, Jan. 2016. 
[158] A. Lorenzini, M. Tresini, S. N. Austad, and V. J. Cristofalo, “Cellular replicative capacity 
correlates primarily with species body mass not longevity.,” Mech. Ageing Dev., vol. 
126, no. 10, pp. 1130–3, Oct. 2005. 
[159] G. E. Gibson, B. Tofel-Grehl, K. Scheffold, V. J. Cristofalo, and J. P. Blass, “A 
reproducible procedure for primary culture and subsequent maintenance of multiple 
lines of human skin fibroblasts.,” Age (Omaha)., vol. 21, no. 1, pp. 7–14, Jan. 1998. 
[160] F. M. Kalfalah et al., “Spatio-temporal regulation of the human licensing factor Cdc6 in 
replication and mitosis.,” Cell Cycle, vol. 14, no. 11, pp. 1704–15, Jun. 2015. 
[161] W. Gorczyca, J. Gong, B. Ardelt, F. Traganos, and Z. Darzynkiewicz, “The cell cycle 
related differences in susceptibility of HL-60 cells to apoptosis induced by various 
antitumor agents.,” Cancer Res., vol. 53, no. 13, pp. 3186–92, Jul. 1993. 
[162] P. L. Olive and J. P. Banáth, “The comet assay: a method to measure DNA damage in 
individual cells,” Nat. Protoc., vol. 1, no. 1, pp. 23–29, Jun. 2006. 
List of references 
102 
 
[163] B. M. Gyori, G. Venkatachalam, P. S. Thiagarajan, D. Hsu, and M.-V. Clement, 
“OpenComet: An automated tool for comet assay image analysis,” Redox Biol., vol. 2, 
pp. 457–465, 2014. 
[164] T. Mosmann, “Rapid colorimetric assay for cellular growth and survival: application to 
proliferation and cytotoxicity assays.,” J. Immunol. Methods, vol. 65, no. 1–2, pp. 55–
63, Dec. 1983. 
[165] L. Cong et al., “Multiplex Genome Engineering Using CRISPR/Cas Systems,” Science 
(80-. )., vol. 339, no. 6121, 2013. 
[166] J. D. Sander and J. K. Joung, “CRISPR-Cas systems for editing, regulating and targeting 
genomes,” Nat. Biotechnol., vol. 32, no. 4, pp. 347–355, Mar. 2014. 
[167] N. A. P. Franken, H. M. Rodermond, J. Stap, J. Haveman, and C. van Bree, “Clonogenic 
assay of cells in vitro.,” Nat. Protoc., vol. 1, no. 5, pp. 2315–9, Dec. 2006. 
[168] G. M. Zúñiga-González et al., “Micronucleated erythrocyte frequencies in old and new 
world primates: measurement of micronucleated erythrocyte frequencies in 
peripheral blood of Callithrix jacchus as a model for evaluating genotoxicity in 
primates.,” Environ. Mol. Mutagen., vol. 46, no. 4, pp. 253–9, Dec. 2005. 
[169] S. B. Dass, S. F. Ali, R. H. Heflich, and D. A. Casciano, “Frequency of spontaneous and 
induced micronuclei in the peripheral blood of aging mice.,” Mutat. Res., vol. 381, no. 
1, pp. 105–10, Nov. 1997. 
[170] E. Croco, S. Marchionni, and A. Lorenzini, “Genetic instability and aging under the 
scrutiny of comparative biology: a meta-analysis of spontaneous micronuclei 
frequency,” Mech. Ageing Dev., vol. 156, pp. 34–41, Jun. 2016. 
[171] G. Zúñiga et al., “Spontaneous micronuclei in peripheral blood erythrocytes from 35 
mammalian species.,” Mutat. Res., vol. 369, no. 1–2, pp. 123–7, Jul. 1996. 
[172] M. P. Ramírez-Muñoz et al., “Evaluation of the micronucleus test in peripheral blood 
erythrocytes by use of the splenectomized model.,” Lab. Anim. Sci., vol. 49, no. 4, pp. 
418–20, Aug. 1999. 
[173] G. M. Zúñiga-González et al., “Micronucleated erythrocyte frequencies in old and new 
List of references 
103 
 
world primates: measurement of micronucleated erythrocyte frequencies in 
peripheral blood of Callithrix jacchus as a model for evaluating genotoxicity in 
primates.,” Environ. Mol. Mutagen., vol. 46, no. 4, pp. 253–9, Dec. 2005. 
[174] M. Cristaldi, L. Anna Ieradi, I. Udroiu, and R. Zilli, “Comparative evaluation of 
background micronucleus frequencies in domestic mammals.,” Mutat. Res., vol. 559, 
no. 1–2, pp. 1–9, Apr. 2004. 
[175] J. R. Meier, P. Wernsing, and J. Torsella, “Feasibility of micronucleus methods for 
monitoring genetic damage in two feral species of small mammals.,” Environ. Mol. 
Mutagen., vol. 33, no. 3, pp. 219–25, 1999. 
[176] G. P. Dimri et al., “A biomarker that identifies senescent human cells in culture and in 
aging skin in vivo.,” Proc. Natl. Acad. Sci. U. S. A., vol. 92, no. 20, pp. 9363–7, Sep. 
1995. 
[177] C. L. Nguyen, R. Possemato, E. L. Bauerlein, A. Xie, R. Scully, and W. C. Hahn, “Nek4 
regulates entry into replicative senescence and the response to DNA damage in 
human fibroblasts.,” Mol. Cell. Biol., vol. 32, no. 19, pp. 3963–77, Oct. 2012. 
[178] P.-O. Mari et al., “Dynamic assembly of end-joining complexes requires interaction 
between Ku70/80 and XRCC4.,” Proc. Natl. Acad. Sci. U. S. A., vol. 103, no. 49, pp. 
18597–602, Dec. 2006. 
[179] M. Hayashi et al., “In vivo erythrocyte micronucleus assay III. Validation and 
regulatory acceptance of automated scoring and the use of rat peripheral blood 
reticulocytes, with discussion of non-hematopoietic target cells and a single dose-level 
limit test.,” Mutat. Res., vol. 627, no. 1, pp. 10–30, Feb. 2007. 
[180] I. Udroiu, “Feasibility of conducting the micronucleus test in circulating erythrocytes 
from different mammalian species: an anatomical perspective.,” Environ. Mol. 
Mutagen., vol. 47, no. 9, pp. 643–6, Dec. 2006. 
[181] J. R. Speakman, “Correlations between physiology and lifespan--two widely ignored 
problems with comparative studies.,” Aging Cell, vol. 4, no. 4, pp. 167–75, Aug. 2005. 
[182] A. Seluanov, D. Mittelman, O. M. Pereira-Smith, J. H. Wilson, and V. Gorbunova, “DNA 
List of references 
104 
 
end joining becomes less efficient and more error-prone during cellular senescence,” 
Proc. Natl. Acad. Sci., vol. 101, no. 20, pp. 7624–7629, May 2004. 
[183] C. Garm et al., “Age and gender effects on DNA strand break repair in peripheral 
blood mononuclear cells,” Aging Cell, vol. 12, no. 1, pp. 58–66, Feb. 2013. 
[184] F. d’Adda di Fagagna et al., “A DNA damage checkpoint response in telomere-initiated 
senescence,” Nature, vol. 426, no. 6963, pp. 194–198, Nov. 2003. 
[185] G. Ferbeyre, E. de Stanchina, E. Querido, N. Baptiste, C. Prives, and S. W. Lowe, “PML 
is induced by oncogenic ras and promotes premature senescence.,” Genes Dev., vol. 
14, no. 16, pp. 2015–27, Aug. 2000. 
[186] M. Pearson et al., “PML regulates p53 acetylation and premature senescence induced 
by oncogenic Ras.,” Nature, vol. 406, no. 6792, pp. 207–10, Jul. 2000. 
[187] K. Healy et al., “Ecology and mode-of-life explain lifespan variation in birds and 
mammals.,” Proceedings. Biol. Sci., vol. 281, no. 1784, p. 20140298, Jun. 2014. 
[188] M. Sulak et al., “Correction: TP53 copy number expansion is associated with the 
evolution of increased body size and an enhanced DNA damage response in 
elephants,” Elife, vol. 5, Dec. 2016. 
[189] A. Lorenzini, L. S. Fink, T. Stamato, C. Torres, and C. Sell, “Relationship of spindle 
assembly checkpoint fidelity to species body mass, lifespan, and developmental rate,” 
Aging (Albany. NY)., vol. 3, no. 12, pp. 1206–1212, Dec. 2011. 
[190] A. A. Freitas and J. P. de Magalhães, “A review and appraisal of the DNA damage 
theory of ageing,” Mutat. Res. Mutat. Res., vol. 728, no. 1–2, pp. 12–22, Jul. 2011. 
[191] G. Lattanzi et al., “Lamins are rapamycin targets that impact human longevity: a study 
in centenarians.,” J. Cell Sci., vol. 127, no. Pt 1, pp. 147–57, Jan. 2014. 
[192] H. Willers et al., “DNA Damage Response Assessments in Human Tumor Samples 
Provide Functional Biomarkers of Radiosensitivity.,” Semin. Radiat. Oncol., vol. 25, no. 
4, pp. 237–50, Oct. 2015. 
[193] C. Bourgier et al., “Late side-effects after curative intent radiotherapy: Identification 
List of references 
105 
 
of hypersensitive patients for personalized strategy.,” Crit. Rev. Oncol. Hematol., vol. 
93, no. 3, pp. 312–9, Mar. 2015. 
[194]   Sato et al., “Effect of aging on spontaneous micronucleus frequencies in peripheral   
blood of nine mouse strains: the results of the 7th collaborative study organized by 
CSGMT/JEMS.MMS”. Collaborative Study Group for the Micronucleus Test. 
Environmental Mutagen Society, 1995. 
